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1. INTRODUCTION 
 
 
1.1. UVB-induced processes in the skin and in keratinocytes 
 
 
UVB light, with a wavelength range between 290 and 320 nm, is one of the most 
important physical carcinogens in the environment, and the skin is the first and major 
barrier to protect the body from its harmful effects. The mechanisms by which the skin 
protects against UV damage have been investigated in detail. At the molecular level, 
UVB causes DNA damage, transcriptional changes and apoptosis. Although epidermal 
keratinocytes, the main site of environmental UVB damage, provide a useful model 
system to study UVB-induced cellular responses, information on the molecular pathways 
mediating these processes is currently limited. UVB irradiation changes the expression of 
several genes in keratinocytes, including the p53 nuclear phosphoprotein (1-3). This 
tumour suppressor functions as a transcription factor and has a central role in keratinocyte 
stress responses, including UV-induced responses (1-4). DNA arrays have been used to 
examine the UV-induced change in expression of 6800 genes in epidermal keratinocytes. 
Differential expression of 198 genes was detected in three waves occurring at 0.5–2 h, 4–
8 h, and 16–24 h after UV irradiation (1). 
 
1.2. COP1, the Constitutive Photomorphogenic Protein 1 
 
1.2.1. COP1 in plants 
 
 
The ultimate energy source for virtually all life on earth is sunlight. Only plants and 
some bacteria are able to absorb sunlight directly and plants have developed sophisticated 
mechanisms to sense light conditions and adjust their developmental programs 
accordingly (5). Many components of the light signalling cascades have been revealed 
over the years, mostly by genetic approaches. Among them, COP1 (constitutive 
photomorphogenic protein 1) was one of the first cloned and is one of the most 
extensively studied. The COP1 protein was first identified as a central negative regulator 
of light-regulated development in Arabidopsis thaliana (6, 7). Arabidopsis thaliana 
COP1 (AtCOP1) contains three conserved structural domains: a RING finger at the amino 
terminus mediating ligase activity, a coiled-coil domain in the middle mediating 
dimerization and seven WD40 repeat domains at the carboxyl-terminal end of the protein 
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implicated in the binding of target proteins (5, 8, 9). AtCOP1 functions as an E3 ubiquitin 
ligase targeting several transcription factors for proteosomal degradation in plants (5). In 
the dark, COP1 is confined to the nucleus, where it directs ubiquitylation and proteasomal 
degradation of ELONGATED HYPOCOTYL5 (HY5), HY5-HOMOLOG (HYH), LONG 
AFTER FAR-RED LIGHT 1 (LAF1) and LONG HYPOCOTYL IN FAR RED (HFR1) 
transcription factors that turn on light-activated genes (10). In the light, however, COP1 
resides in the cytoplasm, allowing the light-responsive transcription factors to activate 
their downstream targets (Fig. 1) (5). Among its substrates is the HY5 protein, a basic 
domain/leucine zipper (bZIP) transcription factor, which is one of the key regulators of 
photomorphogenesis under all light conditions, including UVB. COP1 have long been 
known to affect flowering time in response to photoperiod (11, 12). COP1 is responsible 
for the ubiquitination of the transcriptional regulator CONSTANS (CO) which promotes 
flowering under long days (13). It has been shown that the ability of COP1 by regulating 
the abundance of a circadian clock associated protein, GIGANTEA (GI), COP1 may play 
also a role in the modulation of the circadian clock in plants (7, 14).  
 
 
Figure 1. Mode of action of the CUL4–DDB1-COP1–SPA1 E3 ligase. (a) In darkness, COP1 is responsible 
for the proteasome-mediated degradation of transcription factors, such as HY5, that promote 
photomorphogenesis. COP1 forms a tetrameric complex with members of the SPA family (two COP1 s and 
two SPAs) and interacts with the substrate HY5. The WDXR motifs on either COP1 or SPA further mediate 
the interaction with the CUL4–DDB1 core, and the multimeric CUL4–DDB1-COP1–SPA1 E3 ligase is 
assembled. Activated E2s are recruited to the E3, resulting in the poly-ubiquitination of HY5 and its 
degradation. Photomorphogenesis is repressed. (b) Under light, COP1 is inhibited by the activated 
photoreceptors. In blue light, cry1 interacts with SPA1 and sequesters it from COP1, thereby probably 
disrupting the COP1–SPA1 complex that is important for E3 function. Visible light further promotes the 
nuclear export of COP1 for long-term suppression of COP1. As a result of reduced COP1 activity, HY5 
accumulates, binds to its targets and promotes photomorphogenesis. CUL4, CULLIN4; DDB1, 
DAMAGED DNA BINDING PROTEIN 1; RBX1, RING-BOX 1; SPA1, SUPPRESSOR OF PHYA-105 
1; Cry 1, Cryptochrome; Ub, ubiquitin (7). 
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1.2.2. Structural and functional analogy between AtCOP1 and mammalian COP1 
 
Sequence analysis of COP1 orthologs from the Arabidopsis, human and mouse 
genome indicated that the COP1 domain structure is highly conserved in higher plants 
and vertebrates (Fig. 2) (6, 15). The mouse (MmCOP1) and human COP1 (huCOP1) are 
located on chromosome 1 and the high degree of sequence conservation with AtCOP1 
suggested functional conservation (16-18).  
 
 
Figure 2. Schematic representation of COP1 structural domains and the human COP1 locus. Although the 
human COP1 protein exhibits an amino-terminal extension, both mammalian and Arabidopsis thaliana 
COP1 share three common structural domains: an N-terminal RING finger domain, a coiled-coil domain 
and seven WD40 repeats at the carboxyl terminus. Nuclear localization signals (NLS) and nuclear export 
signals (NES) allow COP1 to shuttle between the nucleus and cytosol (16, 18). 
 
In Arabidopsis, three protein complexes have been described: the COP1 complex, 
the COP9 signalosome and the CDD complex. Together they form a part of the regulatory 
network controlling the activity of the ubiquitin-proteasome system. COP1 appears to be 
directly involved in ubiquitinating protein targets for degradation, while the CDD 
complex and CSN appear to have a broader regulatory role in overseeing the 
ubiquitination and degradation process.  
COP1 is the part of the SUPPESSOR OF PHYA SPA complex. The function of 
CULLIN 4 (CUL4)–DNA damage binding protein 1 (DDB1)–COP1–SPA complex is to 
suppress the photomorphogenic program. 
The COP/DET/FUS genes encode proteins that form a large multisubunit complex, 
the COP9 signalosome (CSN). CSN components with the eight-subunits are conserved in 
both plants and animals. The third component of the CSN (CSN3) seem to act upstream 
of COP1 in mammalian cells stimulated by UV. 
COP1 physically interacts with components of the COP10–DDB1–DET1 complex 
(CDD complex), which enhances E2 ubiquitin-conjugating activity in vitro, and which 
has so far only been found in plants (Fig. 3 a) (19). Both COP1 and the CDD complex can 
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interact with the CSN in vivo (20). Although one of the CDD components, COP10, has 
not been identified in mammals, mammalian homologs of DET1 and DDB1 have been 
described (21). In humans, DDB1 has been shown to form additional cullin-4A 
containing E3 ubiquitin-protein ligase complexes that are regulated by the COP9 
signalosome (Fig. 3 b) (22, 23). There is evidence that, similar to AtCOP1, human COP1 
promotes the ubiquitylation of at least some of its substrates by promoting their 
recruitment to the DDB1–CUL4A E3 ligase complexes (21). 
 
 
Figure 3. COP/DET/FUS proteins function collaboratively in mediating protein ubiquitination. The 
majority of the COP/DET/FUS proteins are conserved in both plants (a) and mammals (b). COP1 is able to 
target the bZIP transcription factors HY5 (in Arabidopsis) and c-Jun (in human) for ubiquitination and 
proteasome-mediated degradation (5). 
 
1.2.3. Functions of mammalian COP1 
 
The role of mammalian COP1 (also known as RFWD2) has been revealed from 
experiments carried out mostly on mouse model. MmCOP1 is a member of the COP–
DET–FUS (CONSTITUTIVE PHOTOMORPHOGENIC/DE-ETIOLATED/FUSCA) 
protein family (15).  COP1 is an E3 ubiquitin ligase that is ubiquitously expressed, 
although not at high levels. It mainly resides in the nucleus and a small amount may also 
be present in the cytosol (16). COP1 is primarily involved in the ubiquitylation of various 
protein substrates and itself to trigger their proteasomal degradation (16, 17). COP1 
contributes to UVB-induced signalling in plants and also in human keratinocytes (24). 
Biochemical studies have identified putative targets of mammalian COP1 with relevant 
roles in tumourigenesis, including the oncoproteins JUN and ETV family members, as 
well as the p53 tumour suppressor. Recent genetic studies have identified mutations of 
COP1 in various human cancers. Several studies provided evidences that COP1 itself can 
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be either a tumour suppressor or an oncoprotein, depending on the cellular context (17, 
21, 25). 
 
1.3. The role of COP1 in the UVB response of plant and human cells 
 
 
The epidermis, our first line of defence from UV light, bears the majority of photo 
damage, which results in skin thinning, wrinkling, keratosis, and malignancy. The clinical 
and histological manifestations of UV damage have been well known for some time, but 
the molecular mechanisms that cause them have only recently become a focus of 
concerted studies (26). UVB represents one of the most important environmental hazards 
affecting human skin (3). 
 
1.3.1. COP1 in the UVB response of plants 
 
In contrast the negative regulation observed for visible-light responses, AtCOP1 is a 
critical positive regulator of responses to low levels of UVB. Genome-wide expression 
changes in response to UVB are blocked to a large extent in the Arabidopsis cop1-4 
mutant, and, in addition, AtCOP1 is required for HY5 gene activation (27). According to 
the latest data, UVB triggers the physical and functional disassociation of the AtCOP1–
SPA core complex from CUL4-DDB1 and the formation of a new complex containing the 
UVB photoreceptor, UV Resistance Locus 8 (UVR8). This UVB-induced machinery is 
associated with the positive role of AtCOP1 in facilitating HY5 stability and activity (Fig. 
4) (28). 
 
 
Figure 4. Model for the function of COP1 complex toward HY5 in darkness and under photomorphogenic 
UVB. White arrows indicate the organization of protein complexes. Black bars indicate negative regulation. 
The black arrow indicates positive regulation (28). 
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1.3.2. The role of huCOP1 in the UVB response of keratinocytes and its mechanism 
 
The UVB-dependent molecular network in which p53 plays a pivotal role has not 
been completely revealed yet. TP53 is a transcription factor that functions as a central 
component of most cellular stress responses. Our research group has previously 
demonstrated that one of the p53-interacting partners, the E3 ubiquitin ligase, huCOP1 is 
expressed in keratinocytes in an UVB-regulated manner and is a negative regulator of p53 
as a post-translational modifier (24, 25). The regulation of p53 by huCOP1 in 
keratinocytes is of particular importance, as this role suggests involvement in both 
cellular UV responses and carcinogenesis. MmCOP1 has also been shown to repress c-
JUN mediated AP-1 transcription by linking these substrates to the CUL4A–DDB1–
RBX1–DET1 E3 ligase complex through direct interaction with DET1 (Fig. 5) (17, 21, 
29, 30). COP1 also promotes its own ubiquitylation and degradation, and this process is 
accelerated by DNA damage (31). Lee et al. discovered that the constitutive 
photomorphogenesis 9 signalosome (CSN) plays a role in the control of DNA damage 
and carcinogenesis caused by UV light (32, 33). The COP9 signalosome (CSN) is thought 
to lie upstream of COP1, and several of its components, such as CSN6, interact and 
regulate COP1 stability and activity (34). 
 
 
Figure 5. COP1 promotes ubiquitylation and proteasome-mediated degradation after DNA damage. COP1 
possesses intrinsic E3 ligase activity and can directly promote the transfer of ubiquitin from E2 proteins to 
some of its substrates such as mammalian p53. COP1 also promotes the degradation of JUN and ETS 
variant 1 (ETV1) by linking these substrates to the CUL4A–DDB1–RBX1–DET1 E3 ligase complex 
through direct interaction with DET1 (18, 21, 30). 
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1.4. Gas discharge plasma, the therapeutic gas mixture 
 
The atmospheric pressure gas discharge plasmas are promising candidates for new 
therapeutic tools. Plasma medicine is a new emerging area of interdisciplinary research in 
plasma physics, combining biology, chemistry and physics (35). The gas discharge 
plasma is a mixture of ions, electrons, radicals (reactive oxygen species (ROS) and 
reactive nitrogen species (RNS)), excited species that contribute to the UV radiation, as 
well as is characterized by an electrical field (36). Research in plasma medicine has 
mainly focused on applications in dermatology and aesthetic surgery with the aim to 
support tissue regeneration to improve healing of infected and/or chronic wounds as well 
as to treat infective and inflamed skin diseases (37). 
 
1.4.1. Low-temperature gas discharge plasma for medical application 
 
Low-temperature gas discharge plasmas can have a huge potential in medical 
application through stimulation of living cells and tissues (38-40). It can also be used for 
therapeutic purposes, the treatment of chronic wounds by gas discharge plasmas may 
have selective antimicrobial or antiseptic effect without damaging the surrounding tissue, 
while stimulating the tissue regeneration (37). It has been shown that cold atmospheric 
plasma (CAP) entails no risk on humans in terms of temperature increase, UV radiation 
or by free radical formation by the gas discharge plasma, while can considerably decrease 
the bacterial load of the skin (41). 
Several studies have been conducted aiming to model the wound healing process, 
e.g. the penetration of gas discharge plasma or plasma generated species into the wound 
mimicking model surfaces, such as an agarose gel (42), as well as the transport of species 
and their interaction with the living cells (43, 44). Although the mechanisms of gas 
discharge plasma interaction with living tissues and cells are very complex, few attempts 
have been made to clarify the physical and biological mechanisms. These studies 
investigated the response of the biological system to the different charged species (45), 
neutral species (such as ROS and RNS) and UV radiation (46-48). 
In vivo animal experiments have shown that gas discharge plasma treatment affects 
the genes that are involved in wound healing, tissue injury and repair (49), and promotes 
tissue healing (50). It has been found that gas discharge plasma treatment may promote 
the late phase of inflammation, accelerate re-epithelization and increase wound 
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contraction (51). Clinical tests suggest that wound healing may be accelerated by gas 
discharge plasma treatment, particularly for chronic venous ulcers (52). 
 
1.4.2. Low-temperature gas discharge plasma for wound healing 
 
Investigations conducted at cellular level, such as using scratched cell cultures to 
mimic wounds, can give an insight into the elementary processes taking place during the 
gas discharge plasma treatment. Cell culture studies using human dermal fibroblasts 
showed improved cell migration by gas discharge plasma jet treatment, while cell 
proliferation was not altered (49). In the wound healing process the major contributors are 
the keratinocytes: they migrate to fill in the gap created by the wound. 
Following the evolution after atmospheric plasma jet treatment of a scratch assay of 
HaCaT human keratinocytes cocultivated with Staphylococcus epidermidis it has been 
shown that the scratch can close, which indicates the increased cell death of S. 
epidermidis compared to HaCaT keratinocytes (53). The biological changes induced in 
human keratinocytes by direct and indirect treatment with different gas discharge plasma 
sources have been evaluated and discussed in details (53, 54). In vivo and in vitro 
(scratch) assay studies indicated that keratinocyte proliferation, migration and apoptotic 
mechanisms were not affected by the treatment with the cold atmospheric plasma 
generated with the MicroPlaSter plasma torch system (55). It has been concluded, that a 
two-minute treatment with this gas discharge plasma induces gene expression of key 
regulators important for inflammation and wound healing without causing proliferation, 
migration or cell death in keratinocytes (55). 
 
1.4.3. Gas discharge plasma needle 
 
The plasma needle is a plasma source with a non-thermal atmospheric glow 
discharge ignited at the tip of a needle. From its initial application (56) the plasma needle 
went through a series of transformations, which made it more and more suitable for 
biomedical applications (57-60). Several studies have been conducted, which aimed to 
investigate the effect of the plasma needle on biological samples, such as, reattachment 
and apoptosis of 3T3 mouse fibroblast after plasma treatment (61), the proliferation and 
differentiation of mesenchymal stem cells (60), as well as its bactericidal effect (59, 62). 
Since plasma needle insures the sample to be in direct contact with the active discharge 
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plasma, in contrast with the atmospheric plasma jets where only afterglow species reach 
the sample, makes possible the study of the effect of the active plasma and electric field 
on the wound healing process. 
14 
 
 
2. AIMS 
 
UVB light is one of the most important physical carcinogens in the environment, 
and the skin is the first and major barrier to protect the body from its harmful effects. 
HuCOP1 is involved in the orchestrating of several cellular processes, and contributes to 
cellular stress response after DNA damage caused by UVB. Although it is evident from 
the available data that huCOP1 is a posttranslational regulator of late UV responses in a 
wide range of organisms, it was not known how huCOP1 acts on early transcriptional 
responses in human keratinocytes. 
Low-temperature gas discharge plasmas can have a huge potential in medical 
applications by stimulating the living cells and tissues. In the process of wound healing 
the major contributors are the keratinocytes, which migrate to fill in the gap created by 
the wound. The active discharge plasma generated by the plasma needle gives the 
possibility to study the effect of plasma on the wound healing process. 
 
Therefore, we aimed 
 to establish and characterize a keratinocyte cell line in which the expression of 
huCOP1 is silenced (siCOP1) 
 to investigate the effect of UVB on huCOP1 protein abundance in the siCOP1 cell 
line 
 to characterize the role of huCOP1 in early UVB-induced signalling processes that 
lead to transcriptional changes in keratinocytes 
 to characterize the effect of the gas discharge plasma needle on the proliferation 
and migration of human keratinocytes 
 to verify the influence of a non-thermal atmospheric pressure plasma on the 
wound healing process in human keratinocytes
15 
 
 
3. MATERIALS AND METHODS 
 
3.1. Cell cultures 
 
HPV-KER cells were maintained in keratinocyte serum-free medium (Gibco® 
Keratinocyte SFM Kit; Life Technologies, Copenhagen, Denmark) supplemented with 
1% antibiotic/antimycotic solution (PAA, Pasching, Austria) and 1% L-glutamine (PAA, 
Pasching, Austria) at 37 °C in a humidified atmosphere containing 5% CO2. The medium 
was changed every two days. Stable transformation of HPV-KER II/15 was performed at 
approximately 70% confluency in supplement-free medium with either the empty vector 
(pSuperior puro vector) or a vector harbouring huCOP1 silencing sequences (24). Plasmid 
DNA for transfection was purified with the QIAGEN Plasmid Maxi Kit (QIAGEN, 
Hilden, Germany). Transfection was carried out with the X-tremeGENE 9 DNA 
Transfection Reagent (Roche Applied Science, Mannheim, Germany) and the Human 
Keratinocyte Nucleofector Kit (Lonza Cologne AG, Cologne, Germany) according to the 
manufacturer’s instruction. 
 
3.2. Cell viability measurements 
 
Keratinocytes were plated into the special golden-coated plates of the xCELLigence 
system (96-well plates) with a density of 10,000 cell/well in a keratinocyte serum-free 
medium (Gibco® Keratinocyte SFM Kit; Life Technologies, Copenhagen, Denmark), 
which contains EGF (epidermal growth factor) and BPE (bovine pituitary extract) as 
supplements. For the plasma treatment 5×103 cells per well were seeded into the 96-well 
plates 48 h before performing the irradiation. Growth of the cells was followed for 6 days. 
Cell viability of the established keratinocyte cell lines was measured with the 
xCELLigence RTCA System (63) following the manufacturer’s instructions (Roche 
Applied Science, Mannheim, Germany). This system makes use of impedance detection 
for continuous monitoring of cell viability. 
 Staining by propidium iodide (PI) is an applicable technic to distinguish dead cells 
from living ones. Forty-eight hours after plasma treatment, keratinocytes were stained 
with PI (BD Pharmingen, Heidelberg, Germany). After washing with calcium- and 
magnesium-free phosphate-buffered saline (PBS), the cells were incubated with PI (final 
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concentration: 1 ug/ml) for 30 min in the darkness. The cells were observed afterwards 
using an Olympus Fluoview FV1000 confocal laser scanning microscope (Olympus Life 
Science Europa GmbH, Hamburg, Germany). The microscope configuration was the 
following: the objective was UPlanSApo 10× (dry, numerical aperture: 0.4), the 
excitation source was a 543 nm HeNe laser, the laser transmissivity was 50%; and the PI 
(propidium iodide) filter settings of the Olympus Fluoview software were used for 
detection. 
 
3.3. UVB irradiation 
 
For irradiation, the medium covering the keratinocytes was replaced with 500 μl 
phosphate-buffered saline (PBS). In preliminary experiments, 10, 20, 40 mJ/cm2 UVB 
doses were used to determine the most appropriate dose for further studies. The 40mJ/cm2 
dose resulted in a decrease in cell viability, whereas the 20 mJ/cm2 found to be the 
highest nonlethal UVB dose. It was also demonstrated that the 20 mJ/cm2 dose effected 
the expression of well-known UVB-inducible genes (G0S2, JUNB, JUND). Cells were 
irradiated with a 20 mJ/cm2 dose of 312 nm UVB in subsequent experiments from an 
FS20 lamp (Westinghouse, Pittsburgh, PA). This instrument emits radiation of 
wavelength ranging between 250 and 400 nm, peaking at 310 nm. After UVB treatment, 
PBS was replaced with 2 ml fresh medium. Control cells were subjected to the identical 
procedure without UVB treatment. 
 
3.4. Western blot analysis 
 
Cells were washed twice with PBS and protein was extracted by suspending 1.0 
million cells in a 100 µl solution containing 20 mM HEPES (4-(2-hydroxyethyl)-1-
piperazineethanesulfonic acid), 150 mM KCl, 1 mM MgCl2, 1 mM DTT (dithiothreitol), 
0.5% Triton-X 100, 10% Glycerol, 0.1% NP-40 (nonyl phenoxypolyethoxylethanol) and 
0.5% SDS, 1%  Protease Inhibitor Cocktail, 1% PMSF (phenylmethylsulfonyl fluoride). 
Protein lysates were incubated for 30 min on ice, then the cell debris was removed by 
centrifugation at 10.000 g for 10 min at 4 °C. For the Western blot analysis, equal 
amounts of total protein extracts were run on SDS-PAGE and then transferred onto a 
nitrocellulose (Bio-Rad Laboratories) or PVDF membrane (Merck Millipore Corporation, 
Billerica, MA, USA). Membranes were blocked by incubation in Tris-buffered saline 
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(150 mM NaCl, 25 mM Tris, pH 7.5) containing 0.05% Tween 20 (Sigma-Aldrich) and 
3% nonfat dry milk (Fluka Chemie AG, Neu-Buchs, Switzerland) for 2 hours at room 
temperature and subsequently incubated overnight at 4 °C with primary antibody (Table 
1). After incubating with secondary antibody (Table 2), the blots were washed, than 
developed using 5-bromo-4-chloro-3-indolyl phosphate/nitro blue tetrazolium as a 
substrate (Sigma-Aldrich, St Louis, MO) or with the Immobilon Western 
Chemiluminescent HRP substrate (Merck Millipore Corporation, Billerica, MA, USA). 
Luminescent signals were detected using a liquid-nitrogen-cooled charge-coupled-device 
camera (Micromax; Roper Scientific Canada). The subsequent semiquantitative analysis 
was carried out using the Metamorph software (Universal Imaging Corp., Sunnyvale, 
California, United States). 
 
Primery antibodies 
Specificity of the antibody Dilution Produced in Producer Development 
COP1 400 rabbit Bethyl Laboratories Chemiluminescens 
α-Actin 500 rabbit Sigma-Aldrich Chemiluminescens 
Table 1. Properties of the primer antibodies used for western blot 
 
Secondary antibodies       
Specificity of the antibody Dilution Produced in Producer 
anti-rabbit IgG–HRP  20000 goat Dako 
Table 2. Properties of the secondary antibodies used for western blot 
 
3.5. Immunocytochemistry 
 
Keratinocytes were grown on culture slides (BD Falcon, Bedford, MA) and were 
immunostained 48 hours after seeding (in other case 24 hours after UVB irradiation). The 
cells were fixed with 2% paraformaldehyde for 5 minutes, and incubated in 2% PFA-
PBS-Triton-X 100 for 10 minutes. Blocking was carried out in a staining solution 
containing Tris-buffered saline (TBS) containing 0.05% Triton-X (Sigma, St. Louis, MO, 
USA) and 0.5% BSA (Sigma, St. Louis, MO, USA) supplemented with 1% goat serum. 
Samples were incubated with primary antibody overnight at 4 ºC (Table 3). After rinsing 
with TBS, sections were incubated with Alexa Fluor 488- or 647-labeled secondary 
antibody (Life Technologies, Carlsbad, CA) at a dilution of 1:400 for 3 hours in the dark 
at room temperature. DNA was stained with 4,6-diamidino-2-phenylindole (DAPI) 
(Sigma Aldrich, St. Louis, MO, USA) at a dilution of 1:100 to detect nuclei. A Zeiss 
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AxioImager fluorescent light microscope (Carl Zeiss MicroImaging, Thornwood, NY, 
USA) fitted with a PixeLINK CCD camera (PixeLINK, Ottawa, ON, Canada) was used 
for detection. The subsequent semiquantitative analysis was performed with Metamorph 
software (Universal Imaging Corp., Sunnyvale, California, United States). 
 
Primery antibody         
Specificity of the antibody Dilution Produced in Producer Development 
COP1 400 rabbit Bethyl Laboratories Fluorescent 
Secondary antibody         
Specificity of the antibody Dilution Produced in Producer Development 
Alexa Fluor-488 400 goat Life Technologies Fluorescent 
Table 3 Properties of the antibodies used for immunocitochemistry 
 
3.6. Real-time RT–PCR array 
 
Total RNA was isolated from the cells using the Direct-zol™ RNA MiniPrep 
(Zymo Research Corporation, Irvine, CA, USA) following the manufacturer’s 
instructions. cDNA was synthesized from 5 µg total RNA with the Maxima First Strand 
cDNA Synthesis Kit for RT-PCR (Thermo Scientific, Waban, MA, USA). Gene 
expression profiling was carried out with the custom-made StellARray™ Gene 
Expression System (Bar Harbor BioTechnology, Trenton, ME) carrying 30 UVB-
regulated genes. RT-PCR array was carried out using the Dynamo Flash SYBR Green 
RT-PCR Kit (Thermo Scientific, Waban, MA, USA). The RT-PCR arrays were 
performed with the ABI Prism 7300 PCR machine (Life Technologies, Copenhagen, 
Denmark). The expression of each gene was normalized to the 18S ribosomal RNA gene. 
Results are averages of three parallel experiments. The relative mRNA expression levels 
were calculated by the ΔΔCt method (64). 
 
3.7. Validation of the real-time RT-PCR experiments 
 
The validation real-time RT–PCR experiments were carried out with the Universal 
Probe Library system (F. Hoffmann-La Roche AG, Basel, Switzerland). Sequences of the 
primers used for PCR amplification of the FOS, G0S2, JUNB, JUND ZFP36, SIK1, ERK, 
CREB1, IL1B, IL6 and NFkB1 genes are listed in Table 4. The expression of each gene 
was normalized to the 18S ribosomal RNA gene. Results are averages of three parallel 
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experiments. The relative mRNA expression levels were calculated by the ΔΔCt method 
(64). 
 
Gene name Primers (5'-3') 
Probe 
number 
JUND 
FWD: CAGCGAGGAGCAGGAGTT 
81 REV: GAGCTGGTTCTGCTTGTGTAAAT 
G0S2 
FWD: GGAGGAGAACGCTGAGGTC 
15 REV: TTTCCATCTCGGCTCTGG 
JUNB 
FWD: ATACACAGCTACGGGATACGG 
45 REV: GCTCGGTTTCAGGAGTTTGT 
FOS 
FWD: CCCAAGTGTGCAAGCTCAG 
67 REV: CCCCAAGAACCTCGGAAG 
ZFP36 
FWD: ACTACCACTCACCCGCAGAC 
58 REV: CCAGGTCCGTGCAGAAGT 
SIK1 
FWD: CATCCCCTTCTTCATGTCTCA 
77 REV: GATCTGGGCGATGGTGAT 
ERK 
FWD: CAAAGAACTAATTTTTGAAGAGACTGC 
20 REV: TCCTCTGAGCCCTTGTCCT 
CREB 
FWD: GGAGCTTGTACCACCGGTAA 
50 REV: GCATCTCCACTCTGCTGGTT 
IL1B 
FWD: AAAGCTTGGTGATGTCTGGTC 
10 REV: AAAGGACATGGAGAACACCACT 
IL6 
FWD: CAGGAGCCCAGCTATGAACT 
45 REV: GAAGGCAGCAGGCAACAC 
NFKB 
FWD: ACCCTGACCTTGCCTATTTG 
39 REV: AGCTCTTTTTCCCGATCTCC 
Table 4. Primer sequences used for the validation real-time RT-PCR detection.  
 
3.8. Pathway analysis 
 
Pathway analysis was performed using the Ingenuity Pathway Analysis software 
(IPA, Ingenuity Systems, Stanford, USA). This software analyses mRNA expression data 
in the context of known biological responses and regulatory networks as well as other 
higher-order response pathways. Ingenuity functional analysis is capable of identifying 
biological functions and/or diseases that are most significant to the detected gene 
expression changes. Genes from the data set that met the twofold (P<0.01) change cut-off 
and were associated with biological functions in the Ingenuity Pathways Knowledge Base 
were considered for analysis. For all analyses, Fisher’s exact test was used to calculate a 
P-value determining the probability that each biological function assigned to that data set 
was due to chance alone. All edges are supported by at least one published reference or 
from canonical information stored in the Ingenuity Pathways Knowledge Base. IPA uses 
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a z-score algorithm to make predictions. The z-score algorithm is designed to reduce the 
chance that random data will generate significant predictions. 
 
3.9. Gas discharge plasma treatment 
 
In order to investigate the effect of the gas discharge plasma on the cells the gas 
discharge generated at the tip of the needle, the so-called plasma needle was used. The 
needle consisted of a 0.3 mm diameter central electrode made of wolfram. The needle 
was covered by a slightly larger ceramic tube - except for a 2 mm segment at the tip - and 
placed in a glass tube of 4 mm inner and 6 mm outer diameter. The tip of the needle was 
placed in line with the edge of the glass tube. The needle body was made of Teflon. 
Helium was flowing between the ceramic and the glass tube, the flow rates used were in 
the 1 - 1.45 slm (standard liters per minute) range. In order to make sure that the needle 
was kept always at the safe distance from the sample during treatments, the plasma 
needle has been mounted onto a holder (Fig. 6-7). This distance has been set to 1.5 mm, 
which assured a stable glow discharge operation without considerably increasing the 
temperature of PBS during the treatment time. The discharge was operated in the 15-30W 
input power range and the dissipated plasma power was estimated to be less than 0.5 W. 
Optical emission spectra in the 250-800 nm spectral range showed the dominance of the 
He lines, accompanied by the O atomic line, the OH and low intensity N2 and N2
+ bands 
(65). 
Two types of cell treatment experiments were conducted: (i) wound-healing model 
and (ii) proliferation experiments, which required the use of two different types of cell 
plates. All the experiments have been performed in a sterile biosafety cabinet. In the first 
case, for the wound-healing assay treatment we used a 24-well plate (Corning, Sigma-
Aldrich, USA), which had wells of 16 mm diameter and 20 mm height. Here the cells 
attached to the bottom of the well were covered with a PBS layer of 1.5 mm thickness, 
and the needle was approached to 1.5 mm distance to the PBS surface. The flow rate of 
helium was 1 slm. During treatments the visible plasma glow covered a 5 mm diameter 
circular area of the sample. In order to limit the treatment environment to predominantly 
helium, the well was covered with a glass lid (Fig. 6). 
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Figure 6. Schematic representation of the experimental set-up used in scratched cell assay experiments. 
 
In the case of the proliferation assay, the cells were treated in 96-well plates, 
protected by 100 μL PBS, using input powers in the range of 18-30 W and treatment 
times in the 5-20 s range. The 96-well plates were placed back into the xCELLigence 
biosensor after all the wells have been treated and the PBS have been changed back to 
cell medium (Fig. 7). 
 
 
Figure 7. Schematic representation of the experimental set-up used in proliferation experiments with cells 
treated in 96-well plates. 
 
3.10. Scratch assay for wound-healing model 
 
In the case of the wound-healing model experiments 1×105 cells per well were 
seeded into 24-well plates. Before treatment a scratch wounding was performed with a 
cell scraper of 4 mm width, according to a well-established in vitro wound-healing assay 
(Fig. 8) (66). For plasma treatment, the medium covering the keratinocytes were replaced 
with PBS. The treatment conditions were set as follows: (i) cells were covered with 
300μL PBS; (ii) the input power was changed in the 18-30 W range and (iii) the treatment 
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time was varied in the 5-30 s range. The evolution of the scratch in time was observed 
and recorded using a Nikon Eclipse TS100 inverted routine microscope (Nikon 
Incorporation, Melville, USA) fitted with a Nikon Coolpix 4500 camera (Nikon 
Incorporation, Melville, USA). The width of the scratch was measured using the Gimp2 
software (Web Networks Inc., Tampa, FL, USA). The scratch width reduction was 
calculated by subtraction of scratch width at t = n hours from scratch width at t = 0 h. 
 
 
Figure 8. Image of the scratched cell culture. For a better contrast the assay was painted with Trypan Blue. 
Four-fold magnification. 
 
3.11. Cocultivation of Propionibacterium acnes and keratinocytes 
 
P. acnes (ATCC 11828) was cultivated in KER-SFM medium with supplements 
during 24 h. In order to determine the concentration of P.acnes in suspension its optical 
density at 600 nm was measured by spectrophotometry. The bacterial suspension was 
diluted with PBS to 1×109 cfu/ml cell density. This suspension was transferred into the 
medium covering the keratinocytes, achieving the multiplicity of infection (MOI - the 
ratio of bacteria per cell) 50 microorganisms. The scratch on the cell culture was 
performed before the transfer of suspension, the size of it and the general cell 
performance were observed during 24 h. One day after plasma treatment, keratinocytes 
were stained with Trypan Blue solution 0.4% (Sigma Aldrich, St. Louis, MO, USA) to 
distinguish the dead cells from living ones. 
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4.  RESULTS 
 
4.1. The role of human Constitutive Photomorphogenic Protein 1 in the UVB 
 light response of human keratinocytes 
 
4.1.1. Establishment and characterization of siCOP1 keratinocyte cell lines 
 
To determine the role of huCOP1 in the early UVB response and its influence in the 
p53 or NFkB pathways, we created keratinocyte cell lines in which the expression level 
of huCOP1 was stably decreased (67). For this purpose, we used the HPV-immortalized 
keratinocyte cell line in which the UVB response of p53 is intact (68). Four cell lines 
harbouring the empty vector and three cell lines carrying the huCOP1 silencing sequences 
were established. 
To select the most appropriate cell lines for further investigation, the degree of 
huCOP1 silencing and the proliferation of the cell lines were compared. Based on the 
results of these preliminary experiments, two cell lines — control and siCOP1 — were 
selected. Semiquantitative analysis of chemiluminescent western blot experiments 
demonstrated that the expression of huCOP1 in the siCOP1 cell line was decreased by 
70% compared to the control line (Fig. 9 a-b). The silencing of huCOP1 did not affect cell 
proliferation (Fig. 10). 
 
Figure 9. HuCOP1 protein expression in keratinocytes. (a) HuCOP1 protein levels from control and 
siCOP1 cell lines were detected by chemiluminescent western blot analysis. (b) The huCOP1 expression 
was subjected to semiquantitative analysis. The expression of huCOP1 was normalized to the expression of 
α-actin. The average of three independent experiments is shown. 
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Figure 10. Dynamic proliferation curves for siCOP1 and control cells. Cell viability of the established 
keratinocyte cell lines was measured with the xCELLigence RTCA System. Black line: control cells; gray 
line: siCOP1 cells. 
 
4.1.2. UVB irradiation decreased huCOP1 protein abundance in transformed cell 
 lines 
 
We previously reported that huCOP1 levels decreased in human keratinocytes after 
UVB irradiation (24, 67). To confirm that the stably transformed cell lines react similarly 
to UVB irradiation, we compared unirradiated and UVB-irradiated control and siCOP1 
cells using the semiquantitative immunocytochemical approach to detect huCOP1 
expression. The 40 mJ/cm2 dose resulted in a decrease in cell viability, whereas the 
20mJ/cm2 found to be the highest nonlethal UVB dose. It was also demonstrated that the 
20 mJ/cm2 dose effected the expression of well-known UVB-inducible genes (G0S2, 
JUNB, JUND). The applied UVB (20 mJ/cm2) did not have a significant effect on the 
viability or proliferation of the cells (Fig. 11).  
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Figure 11. Dynamic proliferation curves for siCOP1 and control cells following UVB irradiation. Cell 
viability of the established keratinocyte cell lines was measured with the xCELLigence RTCA System. 
Gray line: control cells; black line: siCOP1 cells. 
 
An approximately 50% decrease in huCOP1 expression was detected in both cell 
lines 24 h after UVB irradiation (Fig. 12). 
 
 
Figure 12. UVB irradiation decreases huCOP1 protein level in keratinocytes. (a) Unirradiated and UVB-
irradiated control and siCOP1 cells 24 h after treatment. (b) Semiquantitative analysis of huCOP1 protein 
level detected by immunocytochemistry before and at 24 h after UVB irradiation. Results are the averages 
of the huCOP1 expression after UVB irradiation from 30 independent cells normalized to the control cell 
line. 
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4.1.3. Array analysis of selected genes differentially expressed in early UVB 
response revealed a transcriptional regulatory role for huCOP1 in keratinocytes 
 
To understand the role of huCOP1 in the UVB-induced early signalling processes 
of human keratinocytes, we performed an expression profile analysis. For this purpose, 
the siCOP1 and control cell lines were evaluated using the StellARray™ Gene 
Expression System. 
At first, we determined the appearance of the early robust UVB-caused gene 
expression changes in keratinocytes. To measure the kinetic changes in mRNA 
expression of well-known UVB-inducible genes (G0S2, JUNB and JUND), control 
keratinocytes were harvested at various time points (0, 1, 2, 3, 4 and 6 hours) after 
exposure to 10, 20, 40 mJ/cm2 UVB doses (n=3). The G0S2, JUNB and JUND mRNA 
expressions were determined by real-time RT-PCR. It was demonstrated that the 
20mJ/cm2 dose effected the expression of well-known UVB-inducible genes (G0S2, 
JUNB and JUND) and the most robust changes appeared at 2 hours after UVB (Fig. 13). 
Based on published data (1-3), we selected a set of genes showing 2–4-fold changes 
in gene expression within 2 h after UVB irradiation (14 up- and 16 down-regulated 
genes). The expression of the selected genes was compared in unirradiated and UVB-
irradiated cells 2 h after treatment. Changes in gene expression in the control cells were in 
good agreement with published results for most genes. The decreased abundance of 
huCOP1 protein in the siCOP1 cells further modulated this UVB effect, resulting in an 
overall higher gene expression level. Expression of the genes was similar in unirradiated 
siCOP1 and control lines, indicating that the silencing of COP1 had no direct effect on the 
expression of these genes in the absence of UVB (Table 5). 
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Figure 13. Determination of UVB-regulated mRNA expressions in keratinocytes. The G0S2, JUNB and 
JUND mRNA expression after the UVB treatment was determined by real-time RT-PCR. The average of 
three independent experiments is shown. 
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Gene 
symbol 
Entrez 
Gene 
ID Gene name Without UVB 
UVB irradiated 
Change, fold P-values 
Upregulated 
genes     Control siCOP1 Control siCOP1 Control siCOP1 
FOS 2353 
FBJ murine osteosarcoma viral 
oncogene homolog 13,53 14,20 4,95 10,14 0,004 0,006 
DUSP1 1843 Dual specificity phosphatase 1 11,99 11,94 6,62 6,35 0,004 0,020 
BTG2 7832 
Antiproliferative DNA damage 
response 11,77 12,28 3,43 5,65 0,038 0,021 
BTG1 694 
Antiproliferative DNA damage 
response 16,13 16,45 2,27 3,35 0,047 0,084 
ZFP36 7538 
Zinc finger transcriptional 
regulator 14,02 14,33 2,39 4,15 0,050 0,073 
JUNB 3726 Jun B proto-oncogene 10,42 11,30 2,05 2,58 0,058 NS 
JUND 3727 Jun D proto-oncogene 10,54 11,32 1,85 4,92 NS NS 
G0S2 50486 G0/G1 switch gene 10,38 10,52 1,56 2,68 NS NS 
GADD45A 1647 
Growth arrest and DNA-
damage-inducible 12,10 11,28 2,39 2,19 NS NS 
ID3 3399 
HLH1R21 helix-loop-helix 
protein 12,63 13,08 1,41 1,91 NS NS 
NOS1 4842 Neuronal nitric oxide synthase 19,78 19,51 1,23 1,65 NS NS 
SERPINA1 5265 
Serine (or cysteine) proteinase 
inhibitor A1 12,65 11,75 1,10 1,60 NS NS 
IFI27 3429 IFN-inducible 18,14 18,41 1,04 2,14 NS NS 
TAF10 6881 Transcription factor tafII30 10,78 10,70 1,08 1,58 NS NS 
Downregulated 
genes                 
SIK1 150094 
SWI/SWF complex 170 kDa 
subunit (BAF170) 12,17 12,54 -2,59 -1,48 0,019 0,055 
         
PDLIM5 10611 LIM domain 11,33 12,13 -1,98 1,04 0,043 NS 
KLF5 688 GC box binding protein BTEB2 9,92 11,00 -1,96 1,40 0,057 NS 
SRF 6722 Serum response factor 12,99 13,37 -1,75 -1,10 NS 0,061 
MLL 4297 
Translocation T(4:11) of ALL-1 
gene to chr,4 13,50 13,56 -1,75 -1,20 NS NS 
FKBP5 2289 
Progesteron receptor-
associated FJBP54 11,28 11,40 -1,67 1,08 NS NS 
CSNK2A1 1457 Casein kinase II A 11,13 10,82 -1,58 1,07 NS NS 
CSNK1A1 1452 Casein kinase 1A 11,31 11,16 -1,52 1,05 NS NS 
METAP2 10988 
Methionin aminopeptidase, 
translation inhibitor 10,57 10,50 -1,48 1,22 NS NS 
HES1 3280 Transcription factor HRY 10,21 10,70 -1,09 1,67 NS NS 
PPARG 5468 PPAR gamma 14,31 13,80 -1,21 1,47 NS NS 
PKMYT1 9088 
Myt1 kinase (preferentially 
phosphhorylates Cdc2) 14,48 14,36 -1,13 1,44 NS NS 
DAXX 1616 FAS binding protein 12,54 12,67 -1,26 1,51 NS NS 
H2AFZ 3015 Histone 8,36 8,03 -1,07 1,70 NS NS 
PCNA 5111 
Proliferating cell nuclear 
antigen 9,23 9,49 -1,15 1,89 NS NS 
ARF6 382 
ADP ribosilation factor 6 GTP 
binding 10,64 10,23 -1,20 1,12 NS NS 
Table 5. Changes in gene expression of unirradiated and UVB-irradiated control and siCOP1 keratinocytes 
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To verify the array results, we performed real-time RT–PCR analyses of four genes: 
FBJ murine osteosarcoma viral oncogene homolog (FOS), JUND, zinc finger 
transcriptional regulator (ZFP36), and salt-inducible kinase 1 (SIK1) - based on the robust 
UVB-induced changes in gene expression observed in the array experiment. The real-time 
RT–PCR assay of independent biological samples (n=3) confirmed that the detected 
differential expression was a transcriptional consequence of huCOP1 silencing (Fig. 14). 
 
 
Figure 14. Validation of the array data by real-time RT-PCR analysis. Relative transcript levels of JUND, 
ZFP36, FOS and SIK1 are compared for UVB-irradiated siCOP1 (white bars) and control (black bars) cells. 
Expression levels were normalized to the 18S ribosomal RNA gene. Values reflect the fold change between 
the irradiated control and siCOP1 cells. The average of three independent experiments is shown. 
 
4.1.4. A UVB regulatory network identified by pathway analysis was modified by 
huCOP1 expression 
 
Using the Ingenuity Pathway Analysis software (IPA, Ingenuity Systems, Stanford, 
USA), we identified a regulatory network of UVB-regulated genes in which 13 of the 
selected and analysed 30 genes participated (Fig. 15 a). Mitogen-activated protein kinase 
(ERK1/2), cAMP responsive element binding protein (CREB) and ubiquitin (not included 
in the array experiment) were identified as central organizers of this network. Expression 
of all 13 selected genes increased after UVB irradiation in the siCOP1 cell line, indicating 
that huCOP1 modulates the expression of these genes. To clarify whether the gene 
expression of ERK1/2 and CREB is UVB-regulated, we carried out real-time RT–PCR 
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experiments. UVB irradiation reduced the mRNA level of the central organizers in the 
control cell line and this affect was moderated by huCOP1 silencing (Fig. 15 b). 
 
 
Figure 15. The UVB-regulatory network identified by the Ingenuity Pathway Analysis. (a) Arrows with 
continuous lines indicate well established direct regulatory connections between the members of the 
network. Arrows with dashed lines refer to well established indirect connections between the members of 
the network. Gray ovals: UVB upregulated genes; white ovals: UVB down-regulated genes; white 
rectangles: predicted key regulatory molecules. Single-headed arrows: one-way connection. Double-headed 
arrows: determined interaction. Lines without arrows: connection with yet undetermined direction. (b) 
Relative transcript levels of ERK and CREB are compared for UVB-irradiated siCOP1 (white bars) and 
control (black bars) cells. Expression levels were normalized to the 18S ribosomal RNA gene. Values 
reflect the fold change between the untreated and irradiated control and siCOP1 cells from three 
independent irradiation experiments. The applied statistical analysis (Student’s two-tailed heteroscedastic t-
test) did not reveal significant difference in UVB-induced gene expression between the control and siCOP1 
cells, however the tendency is clearly demonstrated. 
 
The pathway analysis also revealed the following upstream regulators of the 
identified network: epidermal growth factor (EGF), nerve growth factor (NGF), fibroblast 
growth factor 2 (FGF2), interferon gamma (IFNG), interleukin-1 beta (IL1B), 
interleukin6 (IL6) cytokines and nuclear factor of kappa beta (NFKB) (Fig. 16 a). 
According to the analysis, these regulators are in an activated state to trigger the UVB 
response through the identified network but the relationships among the upstream 
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regulators were not assessed. We choose three upstream regulator molecules (IL1B, IL6 
and NFKB) to test whether the corresponding genes exhibit UVB-induced changes in 
expression. In agreement with published data (2, 69, 70), our results demonstrated that the 
transcription of these genes is UVB sensitive and that huCOP1 silencing had an effect on 
their transcription levels after UVB irradiation (Fig. 16 b). 
 
 
Figure 16. Predicted upstream regulators of the identified network. (a) White ovals: upstream regulators; 
gray rectangles: UVB-upregulated genes of identified network; white rectangles: UVB-downregulated 
genes of the identified network. All of the upstream regulators were in an activated state, but the 
relationships among them were not investigated. (b) Relative transcript levels of IL1B, IL6 and NFKB are 
compared for UVB-irradiated siCOP1 (white bars) and control (black bars) cells. Expression levels were 
normalized to the 18S ribosomal RNA gene. Values reflect the fold change between the untreated and 
irradiated control and siCOP1 cells in three independent irradiation experiments. The applied statistical 
analysis (Student’s two-tailed heteroscedastic t test) revealed a significant (p < 0.05) difference in the 
expression of the IL6 gene after UVB irradiation of control and siCOP1 cells and demonstrated a non-
significant but tendencious difference in the case of IL1B and NFKB gene expression. 
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4.2. The effect of the gas discharge plasma needle on the human keratinocytes 
 related to the  wound healing processes 
 
4.2.1. Effect of gas discharge plasma treatment on cell viability 
 
In order to optimize the wound-healing model experiments and the safe treatment 
conditions - which do not lead to cell death - viability experiments were performed. For 
this purpose 24-well plates were used with 1×105 cells per well. The treatment parameters 
that could influence the cell survival were: (i) input rf power, (ii) the thickness of PBS 
layer protecting the cells from desiccation, (iii) treatment time and (iv) the distance 
between the tip of the needle and PBS layer, which was set to 1.5 mm. Cells were treated 
under different conditions by varying the input power (18-35 W), PBS layer thickness and 
treatment time (5-30 s). The viability of cells at different conditions were analysed with 
staining methods using trypan blue and propidium iodide. 
 First, cells were stained with trypan blue immediately after gas discharge plasma 
treatment to visualize the effect of the plasma’s structure on the cell culture (dead cells 
take up trypan blue). Figure 17 (a) shows the image of the cell culture treated in 200 μl 
PBS – corresponding to a 1 mm thick PBS layer – for 7 s at 30 W input power. Here we 
could see a pattern of dead cells in the area covered by the plasma glow. More precisely, 
most of the cells died in the treated region, while the cells in contact with the edge of the 
glow detached and diffused towards the central region. On the other hand when 300 μl 
PBS was used instead of 200 μl PBS most of the cells remained viable (Fig. 17 b). 
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Figure 17. (a) The pattern of dead cells caused by gas discharge plasma treatment on cell culture protected 
with 200 μl PBS, equivalent to 1 mm thick layer, when treated for 7 s at 30 W input power. (b) The image 
of cell culture treated in 300 μl PBS for 7 s at 30 W input power. The cells were stained with trypan blue, 
which is taken up by the dead cells. Four-fold magnification. 
 
A more systematic analysis was carried out with the propidium iodide staining 
method. The treated cells were stained 48 h after plasma treatment. The recorded images 
of the cells, indicating the viability of cells) the dead cells stained with propidium iodide 
appear as red) are presented in Figure 18. We have found that the cells covered with 
200μl PBS can survive only very short treatments, such as 5 s at an input power of 
maximum 20 W. The increase of the treatment time or the input power, both led to cell 
death. By increasing the PBS to 250 μl the cells could survive longer treatments at 20 W 
input power, however higher powers were still lethal. When using 300 μl PBS the cells 
could survive treatments as long as 20 s, even at powers as high as 35 W. 
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Figure 18. Keratinocytes 48 h after gas discharge plasma treatment. Image of cells recorded by phase-
contrast light microscopy (1st, 3rd and 5th rows), and confocal laser scanning microscopy image of dead 
cells stained with propidium iodide (2nd, 4th and 6th rows). The treatment conditions, such as PBS layer 
thickness, input power and treatment time, are marked on the images. 
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Viability experiments have also been carried out in 6-well plates, with wells of 
35mm diameter. The volume of the PBS has been scaled up in order to obtain the same 
PBS layer thickness as in the case of the 24-well plate experiments. While in the 24-well 
plate the 1 mm PBS layer corresponded to 200 μL, in the 6-well plate 962 μL needed to 
be added to obtain the same layer thickness. After treating the cells in the 6-well plate at 
conditions leading to cell death in the 24-well plate – such as 5 s treatment at 25 W 
(shown in Fig. 18 first row last column) – most of the cells stayed viable. 
 This result indicated that it was not only the PBS layer thickness, but also the 
liquid surface and volume, which influenced the density of active species reaching the 
cells. Important parameters could also be the heat transport and the heat dissipation 
increased with the volume of the liquid. 
 
4.2.2. Effect of gas discharge plasma treatment on cell proliferation 
 
The effect of the gas discharge plasma treatment on keratinocyte proliferation was 
followed with the xCELLigence microelectronics biosensor. Each well of the plate 
belonging to the device contained integral sensor electrode arrays allowing the 
monitoring of cells. For comparison reasons and to verify whether the liquid composition 
influences the effect of the treatment, cells were also treated in the cell medium. 
Figure 19 shows the proliferation of keratinocytes treated under different conditions 
in PBS (first column) and cell medium (second column). The error bars has been omitted 
from the figures for better visibility. The maximum error is about 12%. We found that 
treatment of keratinocytes at 18 W and 20 W can positively influence cell proliferation 
(Fig. 19 a, c-d). A more significant increase of proliferation could be observed for the 
PBS covered cells in the case of the 10 s and 15 s long treatments at 20 W (Fig. 19 c). 
However in the case of treated cells, the proliferation fell below the control ones after 
60h. This behaviour suggests that periodical treatments could keep the cell proliferation 
above the normal level. At the same time the increase of the treatment time above 15 s, as 
well as the input power (Fig. 19 e-f) cause the diminishing of the proliferation. 
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Figure 19. Cell Index, showing the cell proliferation, as given arbitrary unit by the xCELLigence 
microelectronics biosensor. For initial 5×103 cells are shown treated in PBS (first column) and cell medium 
(second column) for conditions of different treatment times in the 5-20 s range at input powers of 18 W, 20 
W (c-d) and 25 W, respectively. t = 0 marks the time moment when the cells have been recovered after the 
plasma treatment. 
 
In the case of keratinocytes treated in cell medium we could observe a slightly 
different behaviour, i.e. cell proliferation enhanced at a much higher elapsed time after 
plasma treatment. At 20 W this occurred at 100 h after the treatment, except for the 
longest 20 s treatment. This different behaviour showed that due to plasma treatment the 
liquid chemistry of the two liquid mediums - i.e. the created active species, which 
interacted with the cells - was different. We note that the results shown here should not be 
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used for quantitative comparison of the different conditions. All the treatments have been 
performed in a single 96-well plate, i.e. the cells being treated under different conditions 
in a row. The treatments were done in the following order: (1.) P = 18 W from 5 s to 20 s, 
(2.) P = 20 W from 5 s to 20 s, (3.) P = 25 W from 5 s to 20 s, and (4.) P = 30 W from 5 s 
to 20 s. As a result, the cells interacted with the treated liquid for different periods of 
time, which influenced the cellular response to the treatment, as also shown in the next 
section. 
 
4.2.3. Effect of gas discharge plasma treatment on wound-healing 
 
For the wound-healing experiments keratinocytes were plated into 24-well plates. 
The viability of cells was protected by PBS under laboratory conditions during the 
treatment by gas discharge plasma. The cells have been treated by two different treatment 
conditions by using six samples for each case. In the first case, the plates were treated 
two-by-two, meaning that the cell medium was replaced with PBS in two plates at a same 
time, and changed back to medium after both plates have been treated. At each input 
power two plates were treated consecutively as follows: in the 1st plate the 5 s, 7 s, 20 s 
and 25 s treatment times were applied, while in the second plate the 10 s, 15 s and 30 s 
ones. In the second plate the forth row was occupied by the control samples (Table 6). 
 
Treatment 
order
Treatment 
time (s)
Estimated 
elapsed time (s) 
in treated PBS
1 5 1100
2 7 1000
5 10 480
6 15 320
3 20 820
4 25 600
7 30 90  
Table 6. The estimated time while the cells have been covered with the treated PBS after the direct gas 
discharge plasma treatment of the PBS protected cells. The seven different length of treatments have been 
realized in two consecutively treated 24-well plates. The PBS was removed after both plates are fully 
treated. The different elapsed times occurred from the treatment order of the PBS covered cells. 
  
Figure 20 shows the evolution of the scratch on the cell culture as a function of 
input power at different elapsed times after the gas discharge plasma treatment. At several 
treatment conditions - particularly at low treatment times and low powers - the scratch 
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width reduction was higher than in the case of the untreated control, i.e. the closing of the 
scratch was faster. As time elapses, at certain conditions the closing of the scratch slowed 
down compared to the control case, more pronouncedly when 25 W and 30 W powers 
were used. In these cases, at the 48 h elapsed time the scratch width reduction, 
independently of the treatment time used, fell below the control one (Figure 20 d). In the 
case of the lower powers - 18 W and 20 W -, the conditions of low treatment times 
became dominant as time elapsed. This indicates that in order to stimulate the cells, short 
and low power treatments - which induce stress to the cells - may be adequate. 
 
Figure 20. The scratch closure with (a) 15 h, (b) 24 h, (c) 38 h and (d) 48 h after the plasma treatment as a 
function of the input power. Different symbols mark the different treatment times. 
 
In the second case, the plates were treated one-by-one (”plate-by-plate” protocol) 
and in each plate the PBS was replaced with the cell medium 10 min after the last 
treatment in the plate. Figure 21 presents the closing of the scratch after the low power - 
18 W and 20W - treatments as a function of treatment time. In both cases the scratch 
width reduction showed similar non-monotonous behaviour. With 48 h after treatment, 
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the highest scratch width reduction occurred in the case of the lowest treatment time (5 s), 
while the lowest was observed in the case of the 15 s treatment. Furthermore, in the case 
of the 25 s treatment a strong increase of the scratch closing could be observed. It is 
suspected, that this non-monotonous behaviour - with a sharp minimum and maximum - 
could be the result of the treatment protocol used.  
 
Figure 21. The scratch closure as a function of the treatment time for different elapsed times after treatment 
at (a) 18 W and (b) 20 W. 
 
As described in Table 6, two plates were treated consecutively (”two-by-two” 
protocol) when the cells at each condition stayed in the treated PBS for different periods 
of time. According to this, the minimum scratch width reduction could be observed at the 
conditions where the cells were kept in the treated medium for the shortest period of time. 
In order to verify this effect and to find out if the behaviour depicted in Figure 21 should 
be monotonous, a new protocol was chosen, where the plates are treated one by one 
(”plate-by-plate” protocol) and in each plate the PBS was replaced with the cell medium 
10 min after the last treatment in the plate. Although in this way we can not equalize the 
interaction times of treated cells and PBS for all conditions, but by keeping most of the 
parameters the same the large differences can be diminished as presented in Table 7. 
More precisely, in the case of the 10 s and 15 s treatments (Table 7) - where the minimum 
in the scratch width reduction has been observed previously - the treated cell - PBS 
interaction time has been increased to the level of the 5 s treatment condition, where the 
highest scratch width reduction has been obtained previously using the “two-by-two” 
protocol (Table 6). 
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Treatment 
order Plate ID
Treatment 
time (s)
Estimated 
elapsed time (s) 
in treated PBS
1 1 5 1100
2 1 7 1000
1 2 10 1100
2 2 15 950
3 1 20 820
4 1 25 600
3 2 30 690  
Table 7. The estimated time while the cells have been covered with the treated PBS after the direct plasma 
treatment of the PBS protected cells, when the plates were treated one by one and PBS is removed with 10 
min after the plate has been fully treated. 
 
Figure 22 shows the evolution of the scratch after the new protocol treatments at 
18W input power. According to the results, the previously observed sharp minimum and 
maximum of the scratch width reduction as a function of treatment time disappeared. In 
the case of the 10 s and 15 s treatments the scratch width reduction increased 
considerably, comparing to the previous results shown in Figure 21, and as a result a 
faster closing was obtained than in the case of the control sample. This result indicates the 
importance of the treated cell - PBS interaction time. However, in the case of the longest 
investigated treatment - the 30 s treatment - the increase of the treated cell - PBS 
interaction time had no positive effect on the scratch closing. Finally, we could still 
observe a small peak in the scratch width reduction as a function of treatment time at 25 s. 
 
 
Figure 22. The scratch closure as a function of the treatment time for different elapsed times (marked with 
the same symbols as in Figure 20) after the plasma treatment at 18 W using the ”plate-by-plate” treatment 
protocol described in the text. 
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These results indicate that there was a complex association between the cell 
activation, treatment time and treated cell - PBS interaction time. The cell activation was 
influenced both by the direct interaction of cells with the plasma and with the species 
resulted from the plasma induced liquid chemistry. The effect of the treated cell - medium 
interaction time on the cells viability has been also observed by Wende et al (53). 
 
4.2.4. Cell selectivity of the gas discharge plasma treatment 
 
In order to mimic the natural microbial environment of human keratinocytes, they 
were cocultivated with the most common commensal bacteria of the skin, the 
Propionibacterium acnes (P.acnes) Gram-positive bacterium. Figure 23 shows the 
evolution of the scratch in the case of the untreated non-cocultivated and P.acnes 
cocultivated assays, respectively, and the plasma-treated P.acnes cocultivated assay. 
After 24 h the assay has been stained with trypan blue in order to distinguish the dead 
cells. We could see that while in the case of the untreated non-cocultivated and the 
plasma-treated P.acnes cocultivated assays the scratch closed, in the case of the untreated 
P.acnes cocultivated assay the scratch width did not decrease at all and the keratinocytes 
all died. On the other hand, in the case of the plasma-treated sample the keratinocytes did 
not die. This gave evidence that the plasma needle acted selectively regarding the 
keratinocytes and the Gram-positive bacteria. Similar effect has been observed in case of 
treatment of Staphylococcus epidermidis infected HaCaT cells with an argon high-
frequency driven atmospheric-pressure plasma jet treatment (53). 
 
 
Figure 23. The evolution of the scratch in the case of the untreated non-cocultivated and P.acnes 
cocultivated assays, respectively and the plasma-treated P.acnes cocultivated assay. 
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5. DISCUSSION 
 
UVB light is undoubtedly the most important carcinogenic environmental stressor 
of human skin, and UV-induced changes in keratinocytes have been widely studied (3, 
71). 
COP1, the Constitutive Photomorphogenic Protein 1, is well conserved across 
species (6, 7, 15-17). In plants, the function of COP1 is closely tied to the light signalling 
pathway. COP1 acts as a central repressor in the pathway, where it promotes the 
ubiquitination and degradation of the positive regulators and is itself regulated by 
multiple photoreceptors (5, 6). A recent study revealed that under UVB, however, COP1 
acts as a positive regulator in the signalling pathway (27, 28). In mammalians, COP1 
itself can be either a tumour suppressor or an oncoprotein, depending on the context, 
which has important implications for the therapeutic targeting of COP1 and other E3 
ligases (18). Several data suggest that huCOP1 has been implicated in the negative 
regulation of important cancer-related genes acting in the cellular response to UVB (18, 
29). Nevertheless, the possible role of huCOP1 in keratinocyte UVB response and 
tumourigenesis has not yet been investigated in detail. Our aim was therefore to 
investigate the function of huCOP1 in keratinocytes, the cell type most exposed to UVB 
irradiation. 
To address these issues we produced transgenic cell lines in which the expression of 
huCOP1 was stably silenced (siCOP1). For this purpose, a novel, human papillomavirus 
type 16 E6 oncogene-immortalized keratinocyte cell line (HPV-KER) was used and 
characterized. Since this cell line exhibited a normal p53 UVB response, we considered it 
suitable for our purposes (67). 
After establishing the huCOP1 silenced transgenic keratinocyte cell line, we carried 
out viability assays. Our experiments revealed that the silencing of huCOP1 did not affect 
cell viability before and with a short time after UVB irradiation. Next, we examined the 
expression of selected UVB-regulated genes with or without UVB irradiation. Very 
importantly, we found that the residual huCOP1 level was further reduced by UVB and 
the significantly reduced huCOP1 level resulted in more pronounced UVB-induced 
changes in the expression of genes as compared to non-transgenic keratinocytes. These 
data demonstrate that this cell line is a particularly suitable tool for studying huCOP1-
dependent UVB-induced changes in early gene expression responses. 
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In order to elucidate the function of huCOP1 in the early UVB-response of human 
keratinocytes, we carried out array analysis. Our experiments revealed that the expression 
level of the selected genes was not affected by huCOP1 silencing in unirradiated cells. 
DNA array and validating real-time RT–PCR experiments confirmed that transcript levels 
of the selected genes exhibited changes as early as 2 h after UVB irradiation and that 
these changes were in good agreement with previously published data (1-3, 69). 
To analyse the possible interactions among the examined genes we used the 
Ingenuity Pathway Analysis software. This software uses published interaction data for 
composing potential new networks based on novel experimental data. The pathway 
analysis identified a network in which 13 of the 30 examined genes were organized 
around three central molecules, ERK1/2, CREB and ubiquitin. Functional connections 
between certain members of the identified network have already been described (72-75). 
All 13 genes were differentially expressed after UVB irradiation, and their expression 
was increased in siCOP1 cells compared to control. Similar changes have been detected 
in ERK1/2 and CREB gene expression, affirming their central role in the identified 
network. Some of the components of the identified network have already been implicated 
in huCOP1-mediated processes: Liu et al. have recently demonstrated that huCOP1 
promotes the ubiquitination and degradation of the cAMP responsive CREB-regulated 
transcription coactivator 2 (76). HuCOP1 has also been shown to play a role in the 
degradation of the c-Jun protein (17, 18, 29, 30). Our array identified two other functional 
components of the activator protein-1 (AP-1) transcription factor complex: JUNB and 
JUND. HuCOP1 might regulate these two genes through an as yet unidentified 
mechanism. On the basis of these data, we hypothesize that huCOP1 might contribute to 
the regulation of the AP-1 transcription complex at different levels: by altering the 
expression of the JUNB and JUND genes and by promoting the degradation of c-Jun via 
its E3 ubiquitin ligase activity. Such functional interactions were suggested as early as 
2003, when Bianchi and co-workers identified huCOP1 as the human ortholog of 
AtCOP1 and performed the primary functional characterization of the gene and its protein 
product (17). Subsequently, Migliorini et al. demonstrated the direct c-Jun–COP1 
interaction. AP-1-related transcription factors have long been implicated in 
tumourigenesis; therefore, the putative role of huCOP1 in the pathogenesis of human 
cancers emerged early (17, 29). 
Our results and the data available in the literature indicate that decreased huCOP1 
levels sensitize the cells to UVB damage or oxidative stress and modify the UVB-induced 
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stress response of keratinocytes. The loss of some members in the identified network 
increases the sensitivity of the cells to UVB. Maeda et al., for example, demonstrated that 
GADD45A-/- keratinocytes are more sensitive to UVB than GADD45A+/+ cells due to 
reduced DNA repair and lack of G2/M arrest (77). It is also well known that the 
symptoms of systemic lupus erythematosus are exacerbated by sun exposure. Pflegerl et 
al. reported that challenging JUNBDep mice (mice with epidermal loss of JunB) with UVB 
irradiation enhanced the severity of their lupus-like lesions (78). It has also been 
published that DAXX-depleted fibroblasts are resistant to UVB- and oxidative-stress-
induced cell death (79). Presumably, the absence of certain members of the huCOP1-
mediated transcriptional cascade leads to an abnormal UVB response. 
The expression of huCOP1 is altered in non-melanoma skin cancers and several 
members of the identified regulatory network have been implicated in the pathogenesis of 
these skin diseases (80-84). Thus, huCOP1 emerges as a potential target molecule for the 
treatment of BCC and/or SCC. 
 
The devices based on atmospheric pressure gas discharge plasmas are good 
candidates for future medical tools. Physical plasma is a mixture of ions, electrons, 
radicals (ROS and RNS), electric and magnetic fields and UV radiation (36). Low-
temperature gas discharge plasmas can have a huge potential in dermatological 
application based on their unique mixture of reactive components sparking both 
stimulatory as well as inhibitory processes (38-40). During the therapeutic application, 
the treatment of chronic wounds by gas discharge plasmas may have selective 
antimicrobial or antiseptic effect without damaging the surrounding tissue, while 
stimulating the tissue regeneration (49-52). It has been shown that cold atmospheric 
plasma (CAP) entails no risk on humans in terms of temperature increase, UV radiation 
or by free radical formation by the gas discharge plasma, while can considerably decrease 
the bacterial load of the skin (41). Initial studies have been conducted aiming to model the 
wound healing process, e.g. the penetration of gas discharge plasma or plasma generated 
species into the wound mimicking model surfaces (43, 44). However, the mechanisms of 
gas discharge plasma interaction with living tissues and cells are very complex, therefore 
further studies are needed to clarify the physical and biological mechanisms. 
The plasma needle which is a gas discharge plasma source with a non-thermal 
atmospheric glow discharge ignited at the tip of a needle (56), is a suitable device for 
studying biomedical applications (57-60). Since plasma needle insures the sample to be in 
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direct contact with the active discharge plasma - in contrast with the atmospheric plasma 
jets where only afterglow species reach the sample - it is a suitable device to study the 
effect of the active plasma on the wound healing process (53). 
In the wound healing process the major contributors are the keratinocytes, which 
migrate to fill in the gap created by the wound. Therefore, we performed the direct 
treatment of HPV-immortalized human keratinocytes with the glow discharge generated 
in flowing helium by a plasma needle. The cells protected by a layer of phosphate 
buffered saline (PBS) solution were directly treated with the plasma needle. We 
conducted two types of experiments: (i) cell proliferation and (ii) wound-healing model 
experiments. 
In order to choose the optimal plasma needle configuration, the plasma treatment 
conditions and the thickness of the protecting PBS layer, viability experiments were 
carried out. We found that the minimum PBS layer necessary to protect the cells during 
treatment depended on the wells’ dimensions, namely, in larger wells thinner layer 
appeared to be sufficient to protect the cells. This shows the difficulty of scaling the 
treatment conditions. 
The proliferation studies showed that short (5-10 s) and low power (18 W and 20 W 
input power treatments) could positively influence cell proliferation when keratinocytes 
were protected by PBS. We also found that the cells treated in cell medium were more 
affected than those treated in PBS (i.e. cell proliferation decreased), which shows that the 
plasma induced liquid chemistry - i.e. the created active species, which interact with the 
cells - in the two liquid mediums were different. Therefore we concluded that the choice 
of the interaction medium is very important when setting the treatment conditions. 
To study the effect of the plasma needle on keratinocytes related to the wound 
healing process, we modelled it by an in vitro scratch assay. Monitoring the reduction of 
the scratch width after gas discharge plasma treatment for 48 h, we found that there was a 
maximum in the wound reduction as a function of the input power and treatment time, 
namely, at 18 W and 5 s. Nevertheless, favourable conditions were also found in the case 
of 18 W and 20 W input powers and 5-25 s long treatments. We also found that the 
wound reduction strongly depended on the treated cell – PBS interaction time. The effect 
of the treated cell - medium interaction time on the cells viability has been also observed 
by Wende et al (53). 
In the case of the proliferation experiments conducted in the 96-well plates, as 
described, the cells were in contact with the full plasma spot, thus the cell culture was 
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exposed to the whole radial electric field distribution of the plasma in contrast with the 
scratch assay experiments, where only the wings of the field distribution were in contact 
with the cells. Therefore, the differences in the two types of experiments may be 
attributed to the field effect. In what concerns the chemical change of the treated PBS, we 
did not observe any change in the PH level. 
In order to mimic the natural microbial environment of human keratinocytes, they 
were cocultivated with the most common commensal bacteria of the skin, the 
Propionibacterium acnes (P.acnes) Gram-positive bacterium. The gas discharge plasma 
treatment of this assay resulted in closing of the scratch, while in the non-treated assay the 
wound did not close at all. Similar effect has been observed in case of treatment of 
Staphylococcus epidermidis infected HaCaT cells with an argon high-frequency driven 
atmospheric-pressure plasma jet treatment (53). 
The results overall suggest, that for the activation of the healing process a minor 
stress induction of keratinocytes is sufficient, and the treatment medium should be 
carefully chosen. 
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6. SUMMARY 
 
COP1 (constitutive photomorphogenic protein 1) was described in the plant 
Arabidopsis thaliana, as an essential negative regulator of light-mediated plant 
development. COP1 also exists in non-plant multicellular organisms, although its function 
is less understood. The huCOP1 shows a high degree of sequence conservation and 
similar domain organization with AtCOP1, suggesting the possibility of a functional 
conservation as well. The huCOP1, like its plant counterpart, is involved in ubiquitination 
and is itself a substrate of its own ubiquitination activity. UVB light is the most prominent 
genotoxic stress for keratinocytes. Its effect on COP1 expression in human keratinocytes 
has not been investigated previously in details. Our experiments revealed, that huCOP1 
contributes to the transcriptional regulation of the keratinocyte UVB response by the 
down-regulation of an UVB inducible network operating through three newly identified 
central organizers. This network is under the control of upstream regulators also showing 
UVB response. We hypothesize that huCOP1 operates as a negative factor of the 
identified transcriptional network by modifying the function of the upstream regulators. 
Mechanism underlying the UVB-induced cellular events may include a re-distribution of 
huCOP1 to different molecular complexes. Such a mechanism has recently been 
demonstrated for Arabidopsis. The expression of huCOP1 is altered in non-melanoma 
skin cancers and several members of the identified regulatory network have been 
implicated in the pathogenesis of these skin diseases. Thus, huCOP1 emerges as a 
potential target molecule for the treatment of BCC and/or SCC. COP1 possibly acts both 
as an oncogene and as a tumour suppressor. 
 
Atmospheric pressure gas discharge plasmas are promising candidates for new 
therapeutic tools. In the present study we could verify the influence of a non-thermal 
atmospheric pressure plasma on the wound healing process. In this process the major 
contributors are the keratinocytes, which migrate to fill in the gap created by the wound. 
Therefore, we performed the direct treatment of HPV-immortalized human keratinocytes, 
protected by a layer of phosphate buffered saline (PBS) solution, with the glow discharge 
generated in flowing helium by a plasma needle. Our results revealed that plasma could 
positively influence cell proliferation when keratinocytes were protected by PBS. On the 
other hand, the plasma treatment of cell medium covered keratinocytes resulted in the 
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decrease of proliferation. The wound-healing model studies showed that there was a 
maximum in the wound reduction as a function of the input power and treatment time, 
namely, at 18 W and 5 s. Furthermore, the wound reduction strongly depended on the 
treated cell - PBS interaction time. To mimic the natural microbial environment of human 
keratinocytes, they were cocultivated with the most common commensal bacteria of the 
skin, the Propionibacterium acnes (P.acnes) Gram-positive bacterium. The gas discharge 
plasma treatment of this infected assay resulted in closing of the scratch, while in the non-
treated assay the wound did not close at all. The results overall suggest, that for activation 
of the healing process a minor stress induction of keratinocytes is sufficient, and the 
treatment medium should be carefully chosen. 
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a b s t r a c t
Ultraviolet (UV) B is the most prominent physical carcinogen in the environment leading to the develop-
ment of various skin cancers. We have previously demonstrated that the human ortholog of the Arabid-
opsis thaliana constitutive photomorphogenesis 1 (COP1) protein, huCOP1, is expressed in keratinocytes
in a UVB-regulated manner and is a negative regulator of p53 as a posttranslational modiﬁer. However, it
was not known whether huCOP1 plays a role in mediating the UVB-induced early transcriptional
responses of human keratinocytes. In this study, we report that stable siRNA-mediated silencing of
huCOP1 affects the UVB response of several genes within 2 h of irradiation, indicating that altered
huCOP1 expression sensitizes the cells toward UVB. Pathway analysis identiﬁed a molecular network
in which 13 of the 30 examined UVB-regulated genes were organized around three central proteins. Since
the expression of the investigated genes was upregulated by UVB in the siCOP1 cell line, we hypothesize
that huCOP1 is a repressor of the identiﬁed pathway. Several members of the network have been impli-
cated previously in the pathogenesis of non-melanoma skin cancers; therefore, clarifying the role of
huCOP1 in these skin diseases may have clinical relevance in the future.
 2014 Elsevier B.V. All rights reserved.
1. Introduction
Ultraviolet (UV) B light is one of the most important physical
carcinogens in the environment, and the skin is the ﬁrst and major
barrier to protect the body from its harmful effects. At the molec-
ular level, UVB causes DNA damage, transcriptional changes and
apoptosis. Although epidermal keratinocytes, the main site of envi-
ronmental UVB damage, provide a useful model system to study
UVB-induced cellular responses, information on the molecular
pathways mediating these processes is currently limited. UVB irra-
diation changes the expression of several genes in keratinocytes,
including the p53 nuclear phosphoprotein [1–3]. This tumor
suppressor functions as a transcription factor and has a central
role in keratinocyte stress responses, including UV-induced
responses [1–5]. The UVB-dependent molecular network in
which p53 plays a pivotal role has not been revealed yet. One
of the p53-interacting partners, the E3 ubiquitin ligase, COP1
(constitutive photomorphogenic 1), has been intensively studied
in various organisms [6–11].
The COP1 protein was ﬁrst identiﬁed as a central negative reg-
ulator of light-regulated development in Arabidopsis thaliana [12].
A. thaliana COP1 (AtCOP1) contains three conserved structural
domains: a RING ﬁnger at the amino terminus mediating ligase
activity, a coiled-coil domain in the middle mediating dimerization
and seven WD40 repeat domains at the carboxyl-terminal end of
the protein implicated in the binding of target proteins [13–15].
AtCOP1 functions as an E3 ubiquitin ligase targeting selected pro-
teins for proteasomal degradation in plants [15]. Among its sub-
strates are important transcription factors, such as the key
regulators of photomorphogenesis under all light conditions,
including UVB [16]. In contrast the negative regulation observed
for visible-light responses, AtCOP1 is a critical positive regulator
of responses to low levels of UVB. According to the latest data,
UVB triggers the physical and functional disassociation of the
AtCOP1–SPA core complex from CUL4–DDB1 and the formation
of a new complex containing the UVB photoreceptor, UV Resis-
tance Locus 8. This UVB-induced machinery is associated with
the positive role of AtCOP1 in facilitating the stability and activity
of key transcription factors [8].
http://dx.doi.org/10.1016/j.jphotobiol.2014.08.002
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Sequence analysis of COP1 orthologs from arabidopsis, human
and mouse indicated that the COP1 domain structure is highly con-
served in higher plants and vertebrates [16]. The mouse (MmCOP1)
and human COP1 (huCOP1) sequences are located on chromosome
1 and the high degree of sequence conservation with AtCOP1 sug-
gested functional conservation [12]. Both MmCOP1 and huCOP1
target bZIP transcription factors of the Jun family and p53 for deg-
radation in a similar manner to AtCOP1 [6,17]. Lee et al. discovered
that the constitutive photomorphogenesis 9 signalosome (CSN)
plays a role in the control of DNA damage and carcinogenesis
caused by UV light [18,19]. CSN components seem to act upstream
of COP1 in mammalian cells stimulated by UV. Based on this obser-
vation, CSN components might act through huCOP1 in the negative
regulation of important cancer genes, including p53, MDM2, P27,
c-Jun, NFKB, SMAD7, RUNX3, ID1, SKP2 and HIFI [18,19].
The function of huCOP1 has not yet been investigated in detail.
We previously demonstrated that huCOP1 is expressed in keratino-
cytes in an UVB-regulated manner and is a negative regulator of
p53 as a post-translational modiﬁer [10]. The regulation of p53
by huCOP1 in keratinocytes is of particular importance, as this role
suggests involvement in both cellular UV responses and carcino-
genesis. MmCOP1 has also been shown to repress c-Jun mediated
AP-1 transcription [11,20].
The mechanisms by which the skin protects against UV damage
have been investigated in detail. DNA arrays have been used to
examine the UV-induced change in expression of 6800 genes in
epidermal keratinocytes. Differential expression of 198 genes was
detected in three waves occurring at 0.5–2 h, 4–8 h and 16–24 h
after UV irradiation [1]. Although it is evident from the available
data that huCOP1 and orthologs are posttranslational regulators
of late UV responses in a wide range of organisms, it was not
known how early huCOP1 acts on transcriptional responses. Based
on these data and on the results obtained from a UVB-dependent
transcriptome analysis performed with arabidopsis [21], we raised
the question whether huCOP1 plays a role in early UVB-induced
signaling processes that lead to transcriptional changes in
keratinocytes.
In this study we report that stable siRNA-mediated silencing of
huCOP1 sensitizes the keratinocyte cells toward UVB and affects
the UVB response of several genes within 2 h of irradiation. Our
results suggest that huCOP1 plays a role in modulating the early
cellular UVB response at the transcriptional level in human
keratinocytes.
2. Materials and methods
2.1. Keratinocyte transformation
HPV-immortalized human keratinocytes (HPV-KER clone II/15)
were maintained as described [22]. Stable transformation of
HPV-KER II/15 was performed at approximately 70% conﬂuency
in supplement-free medium with either the empty vector (pSupe-
rior.puro vector) or a vector harboring huCOP1 silencing sequences
[10]. Plasmid DNA for transfection was puriﬁed with the QIAGEN
Plasmid Maxi Kit (QIAGEN, Hilden, Germany). Transfection was
carried out with the X-tremeGENE 9 DNA Transfection Reagent
(Roche Applied Science, Mannheim, Germany) and the Human
Keratinocyte Nucleofector Kit (Lonza Cologne AG, Cologne, Ger-
many) according to the manufacturer’s instruction.
2.2. Western blot analysis
HuCOP1 protein was detected using previously described stan-
dard procedures [10] with the exception that anti-mouse IgG–HRP
(Dako Thermo Scientiﬁc Waban, MA, USA) was used as a secondary
antibody at a dilution of 1:1000. Membranes were incubated over-
night at 4 C with puriﬁed rabbit polyclonal anti-huCOP1 antibody.
After treating the membrane with the Immobilon Western
Chemiluminescent HRP substrate (Merck Millipore Corporation,
Billerica, MA, USA), luminescent signals were detected using a
liquid-nitrogen-cooled charge-coupled-device camera (Micromax;
Roper Scientiﬁc Canada).
2.3. Cell viability measurements
Keratinocytes were seeded in 96-well plates at 10,000 cells per
well. Growth of the cells was followed for 6 days. Cell viability of
the established keratinocyte cell lines was measured with the
xCELLigence RTCA System [39] following the manufacturer’s
instructions (Roche Applied Science, Mannheim, Germany). See
Supplementary Methods online for details.
2.4. Immunocytochemistry
Unirradiated and UVB-irradiated control and siCOP1 cells were
immunostained 24 h after UVB exposure. DNA was stained with
4,6-diamidino-2-phenylindole (DAPI). The primary antibody used
for immunohistochemistry was rabbit polyclonal anti-huCOP1
(Bethyl Laboratories, Montgomery, USA). A Zeiss AxioImager ﬂuo-
rescent light microscope (Carl Zeiss MicroImaging, Thornwood,
NY, USA) ﬁtted with a PixeLINK CCD camera (PixeLINK, Ottawa,
ON, Canada) was used for detection. The subsequent semiquantita-
tive analysis was carried out using Metamorph software (Universal
Imaging Corp., Sunnyvale, California, United States). See Supple-
mentary Methods online for details.
2.5. UVB irradiation
For irradiation, the medium covering the keratinocytes was
replaced with phosphate-buffered saline (PBS). In preliminary
experiments, 10, 20, 40 mJ cm2 UVB doses were used to deter-
mine the most appropriate dose for further studies. The
40 mJ cm2 dose resulted in a decrease in cell viability, whereas
the 20 mJ cm2 did not affect cell viability (data not shown). It
was also demonstrated that the 20 mJ cm2 dose effected the
expression of well known UVB-inducible genes (G0S2, JUNB, JUND,
data not shown). Cells were irradiated with a 20 mJ cm2 dose of
312 nm UVB [40] from an FS20 lamp (Westinghouse, Pittsburgh,
PA). After UVB treatment, PBS was replaced with fresh medium.
Control cells were subjected to the identical procedure without
UVB treatment.
2.6. Real-time RT–PCR array and validation experiments
Real-time RT–PCR was performed with a custom-made Stell-
ARray™ Gene Expression System (Bar Harbor BioTechnology, Tren-
ton, ME) carrying 30 UVB-regulated genes. The validation real-
time RT–PCR experiments were carried out with the Universal
Probe Library system (F. Hoffmann-La Roche AG, Basel, Switzer-
land). Sequences of the primers used for PCR ampliﬁcation of
the FOS, JUND ZFP36 and SIK1 genes are listed in Table S1. The
expression of each gene was normalized to the signal from
the 18S ribosomal RNA gene. Results are averages of three parallel
experiments. The relative mRNA expression levels were calculated
by the DDCt method [41]. See Supplementary Methods online for
details.
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2.7. Pathway analysis
Pathway analysis was performed using Ingenuity Pathway
Analysis software (IPA, Ingenuity Systems, Stanford, USA). See Sup-
plementary Methods online for details.
3. Results
3.1. Characterization of siCOP1 keratinocyte cell lines
To determine the role of huCOP1 in the early UVB response, we
created keratinocyte cell lines in which the expression level of
huCOP1 was stably decreased. For this purpose, we used an HPV-
immortalized keratinocyte cell line in which the UVB response of
p53 is intact: its UVB inducibility resembles that of normal human
cultured keratinocytes. However, sequence analysis revealed that
the p53 gene in this cell line harbors the codon 72 polymorphism
of the protein (manuscript in preparation). G-banding analyses of
the cell line revealed normal human karyogram (46, XX) [22]. Four
cell lines harboring the empty vector and three cell lines carrying
the huCOP1 silencing sequences were established. To select the
most appropriate cell lines for further investigation, the degree of
huCOP1 silencing and the proliferation of the cell lines were com-
pared. Based on the results of these preliminary experiments (data
not shown), two cell lines — control and siCOP1 — were selected.
Semiquantitative analysis of chemiluminescent western blot
experiments demonstrated that the expression of huCOP1 in the
siCOP1 cell line was decreased by 70% compared to the control line
(Fig. 1a and b). The silencing of huCOP1 did not affect cell prolifer-
ation (Fig. 2).
3.2. UVB irradiation decreased huCOP1 protein abundance in
transformed cell lines
We previously reported that huCOP1 levels decrease in human
keratinocytes after UVB irradiation [10]. To conﬁrm that the stably
transformed cell lines react similarly to UVB irradiation, we com-
pared unirradiated and UVB-irradiated control and siCOP1 cells
using the semiquantitative immunocytochemical approach to
detect huCOP1 expression. The applied UVB (20 mJ cm2) did not
affect the viability or proliferation of the cells (data not shown).
An approximately 50% decrease in huCOP1 expression was
detected in both cell lines 24 h after UVB irradiation (Fig. 3).
3.3. Array analysis of selected genes differentially expressed in early
UVB response revealed a transcriptional regulatory role for huCOP1 in
keratinocytes
To understand the role of huCOP1 in the UVB-induced early
signaling processes of human keratinocytes, we performed an
expression proﬁle analysis. For this purpose, the siCOP1 and con-
trol cell lines were evaluated using the StellARray™ Gene Expres-
sion System. Based on published data [1–3], we selected a set of
genes showing a 2–4-fold change in gene expression within 2 h
after UVB irradiation (14 up- and 16 down-regulated genes). The
expression of the selected genes was compared in unirradiated
and UVB-irradiated cells 2 h after treatment. Changes in gene
expression in the control cells were in good agreement with pub-
lished results for most genes. The decreased abundance of huCOP1
protein in the siCOP1 cells further modulated this UVB effect,
resulting in an overall higher gene expression level. Expression of
the genes was similar in unirradiated siCOP1 and control lines,
indicating that the silencing of COP1 had no direct effect on the
expression of these genes in the absence of UVB (Table 1).
To verify the array results, we performed real-time RT–PCR
analyses of four genes, FBJ murine osteosarcoma viral oncogene
homolog (FOS), JUND, zinc ﬁnger transcriptional regulator
(ZFP36), and SIK1 (salt-inducible kinase 1) based on the robust
UVB-induced changes in gene expression observed in the array
experiment. The real-time RT–PCR assay of independent biological
samples conﬁrmed that the detected differential expression was a
transcriptional consequence of huCOP1 silencing (Supplementary
Fig. S1).
3.4. A UVB regulatory network identiﬁed by pathway analysis was
modiﬁed by huCOP1 expression
Using the Ingenuity Pathway Analysis software (IPA, Ingenuity
Systems, Stanford, USA), we identiﬁed a regulatory network of
UVB-regulated genes in which 13 of the selected 30 genes
Fig. 1. HuCOP1 protein expression in keratinocytes. (a) HuCOP1 protein levels from control and siCOP1 cell lines were detected by chemiluminescent western blot analysis;
(b) the huCOP1 expression was subjected to semiquantitative analysis. The expression of huCOP1 was normalized to the expression of a-actin. The average of three
independent experiments is shown.
Fig. 2. Dynamic proliferation curves for siCOP1 and control cells. Cell viability of
the established keratinocyte cell lines was measured with the xCELLigence RTCA
System. Black line: control cells; gray line: siCOP1 cells.
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Fig. 3. UVB irradiation decreases huCOP1 protein level in keratinocytes. (a) Unirradiated and UVB-irradiated control and siCOP1 cells 24 h after treatment. (b)
Semiquantitative analysis of huCOP1 protein level detected by immunocytochemistry before and at 24 h after UVB irradiation. Results are the averages of the huCOP1
expression after UVB irradiation from 30 independent cells normalized to the control cell line.
Table 1
Changes in gene expression of unirradiated and UVB-irradiated control and siCOP1 keratinocytes.
Gene symbol Entrez gene ID Gene name Without UVB UVB irradiated change, fold p-Values
Upregulated genes Control siCOP1 Control siCOP1 Control siCOP1
FOS 2353 FBJ murine osteosarcoma viral oncogene homolog 13,53 14,20 4,95 10,14 0,004 0,006
DUSP1 1843 Dual speciﬁcity phosphatase 1 11,99 11,94 6,62 6,35 0,004 0,020
BTG2 7832 Antiproliferative DNA damage response 11,77 12,28 3,43 5,65 0,038 0,021
BTG1 694 Antiproliferative DNA damage response 16,13 16,45 2,27 3,35 0,047 0,084
ZFP36 7538 Zinc ﬁnger transcriptional regulator 14,02 14,33 2,39 4,15 0,050 0,073
JUNB 3726 Jun B proto-oncogene 10,42 11,30 2,05 2,58 0,058 NS
JUND 3727 Jun D proto-oncogene 10,54 11,32 1,85 4,92 NS NS
G0S2 50,486 G0/G1 switch gene 10,38 10,52 1,56 2,68 NS NS
GADD45A 1647 Growth arrest and DNA-damage-inducible 12,10 11,28 2,39 2,19 NS NS
ID3 3399 HLH1R21 helix-loop-helix protein 12,63 13,08 1,41 1,91 NS NS
NOS1 4842 Neuronal nitric oxide synthase 19,78 19,51 1,23 1,65 NS NS
SERPINA1 5265 Serine (or cysteine) proteinase inhibitor A1 12,65 11,75 1,10 1,60 NS NS
IFI27 3429 IFN-inducible 18,14 18,41 1,04 2,14 NS NS
TAF10 6881 Transcription factor tafII30 10,78 10,70 1,08 1,58 NS NS
Downregulated genes
SIK1 150,094 SWI/SWF complex 170 kDa subunit (BAF170) 12,17 12,54 2,59 1,48 0,019 0,055
PDLIM5 10,611 LIM domain 11,33 12,13 1,98 1,04 0,043 NS
KLF5 688 GC box binding protein BTEB2 9,92 11,00 1,96 1,40 0,057 NS
SRF 6722 Serum response factor 12,99 13,37 1,75 1,10 NS 0,061
MLL 4297 Translocation T(4:11) of ALL-1 gene to chr, 4 13,50 13,56 1,75 1,20 NS NS
FKBP5 2289 Progesteron receptor-associated FJBP54 11,28 11,40 1,67 1,08 NS NS
CSNK2A1 1457 Casein kinase II A 11,13 10,82 1,58 1,07 NS NS
CSNK1A1 1452 Casein kinase 1A 11,31 11,16 1,52 1,05 NS NS
METAP2 10,988 Methionine aminopeptidase, translation inhibitor 10,57 10,50 1,48 1,22 NS NS
HES1 3280 Transcription factor HRY 10,21 10,70 1,09 1,67 NS NS
PPARG 5468 PPAR gamma 14,31 13,80 1,21 1,47 NS NS
PKMYT1 9088 Myt1 kinase (preferentially phosphorylates Cdc2) 14,48 14,36 1,13 1,44 NS NS
DAXX 1616 FAS binding protein 12,54 12,67 1,26 1,51 NS NS
H2AFZ 3015 Histone 8,36 8,03 1,07 1,70 NS NS
PCNA 5111 Proliferating cell nuclear antigen 9,23 9,49 1,15 1,89 NS NS
ARF6 382 ADP ribosylation factor 6 GTP binding 10,64 10,23 1,20 1,12 NS NS
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participated (Fig. 4a). Mitogen-activated protein kinase (ERK1/2),
cAMP responsive element binding protein (CREB) and ubiquitin
(not included in the array experiment) were identiﬁed as central
organizers of this network. Expression of all 13 selected genes
increased after UVB irradiation in the siCOP1 cell line, indicating
that huCOP1 modulates the expression of these genes. To clarify
whether the gene expression of ERK1/2 and CREB is UVB-regulated,
we carried out real-time RT–PCR experiments. UVB irradiation
reduced the mRNA level of the central organizers in the control cell
line and this affect was moderated by huCOP1 silencing (Fig. 4b).
The pathway analysis also revealed the following upstream reg-
ulators of the identiﬁed network: epidermal growth factor (EGF),
nerve growth factor, ﬁbroblast growth factor 2, interferon gamma,
interleukin-1 beta, interleukin 6 cytokines and nuclear factor of
kappa beta (NFKB) (Fig. 5a). According to the analysis, these regu-
lators are in an activated state to trigger the UVB response through
the identiﬁed network but the relationships among the upstream
regulators were not assessed. We choose three upstream regulator
molecules (IL1B, IL6 and NFKB) to test whether the corresponding
genes exhibit UVB-induced changes in expression. In agreement
with published data [2,4,23], our results demonstrated that the
transcription of these genes is UVB sensitive and that huCOP1
silencing had an effect on their transcription levels after UVB irra-
diation (Fig. 5b).
4. Discussion
UVB light is undoubtedly the most important carcinogenic envi-
ronmental stressor of human skin, and UV-induced changes in
keratinocytes have been widely studied [3,24]. HuCOP1 has been
implicated in the negative regulation of important cancer-related
genes acting in the cellular response to UVB [11,25]. Nevertheless,
the possible role of huCOP1 in the keratinocyte UVB response has
not yet been investigated in detail.
To address these issues we produced transgenic cell lines in
which the expression of huCOP1 was stably silenced (siCOP1).
For this purpose, we used an HPV-immortalized keratinocyte cell
line carrying the codon 72 polymorphism of the p53 gene, a
well-known and common polymorphism with yet unconﬁrmed
signiﬁcance in cancer risk. Since this cell line exhibited a normal
Fig. 4. The UVB-regulatory network identiﬁed by the Ingenuity Pathway Analysis. (a) Arrows with continuous lines indicate well established direct regulatory connection
between the members of the network. Arrows with dashed lines refer to well established indirect connections between the members of the network. Gray ovals: UVB-
upregulated genes; white ovals: UVB-downregulated genes; white rectangles: predicted key regulatory molecules. Single-headed arrows: one-way connection. Double-
headed arrows: determined interaction. Lines without arrows: connection with yet undetermined direction; (b) relative transcript levels of ERK and CREB are compared for
UVB-irradiated siCOP1 (white bars) and control (black bars) cells. Expression levels were normalized to the 18S ribosomal RNA gene. Values reﬂect the fold change between
the untreated and irradiated control and siCOP1 cells from three independent irradiation experiments. The applied statistical analysis (Student’s two-tailed heteroscedastic t
test) did not reveal signiﬁcant difference in UVB-induced gene expression between the control and siCOP1 cells, however the tendency is clearly demonstrated.
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p53 UVB response, we considered it suitable for our purposes. After
establishing the huCOP1 silenced transgenic keratinocyte cell line,
we examined the expression of selected UVB-regulated genes with
or without UVB irradiation. Our experiments revealed that (i) the
silencing of huCOP1 did not affect cell viability, (ii) the expression
level of the selected genes was not affected by huCOP1 silencing in
unirradiated cells, and (iii) DNA array and validating real-time RT–
PCR experiments conﬁrmed that transcript levels of the selected
genes exhibited changes as early as 2 h after UVB irradiation and
that these changes were in good agreement with previously pub-
lished data [1–4]. However, very importantly, we found that (i)
the residual huCOP1 level was further reduced by UVB and (ii)
the signiﬁcantly reduced huCOP1 level resulted in more pro-
nounced UVB-induced changes in the expression of genes as com-
pared to non-transgenic keratinocytes. These data demonstrate
that this cell line is a particularly suitable tool for studying
huCOP1-dependent UVB-induced changes in early gene expression
responses.
The possible interactions among the examined genes were ana-
lyzed using Ingenuity Pathway Analysis software. This software
uses published interaction data for composing potential new net-
works based on novel experimental data. The pathway analysis
identiﬁed a network in which 13 of the 30 examined genes were
organized around three central molecules, ERK1/2, CREB and
ubiquitin.
Functional connections between certain members of the identi-
ﬁed network have already been described [26–29]. All 13 genes
were differentially expressed after UVB irradiation, and their
expression was increased in siCOP1 cells compared to control. Sim-
ilar changes have been detected in ERK1/2 and CREB gene expres-
sion, afﬁrming their central role in the identiﬁed network.
Some of the components of the identiﬁed network have already
been implicated in huCOP1-mediated processes: Liu et al. [30]
have recently demonstrated that huCOP1 promotes the ubiquitina-
tion and degradation of the cAMP responsive CREB-regulated
transcription coactivator 2. COP1 has also been shown to play a
role in the degradation of the c-Jun protein [9,11,20,25].
Our array identiﬁed two other functional components of the
activator protein-1 (AP-1) transcription factor complex: JUNB and
JUND. HuCOP1 might regulate these two genes through an as yet
unidentiﬁed mechanism. On the basis of these data, we hypothe-
size that huCOP1 might contribute to the regulation of the AP-1
transcription complex at different levels: by altering the expres-
sion of the JUNB and JUND genes and by promoting the degrada-
tion of c-Jun via its E3 ubiquitin ligase activity. Such functional
interactions were suggested as early as 2003, when Bianchi and
co-workers identiﬁed huCOP1 as the human ortholog of AtCOP1
and performed the primary functional characterization of the gene
and its protein product [20]. Subsequently Migliorini et al. (2011)
demonstrated the direct c-Jun–COP1 interaction.
AP-1-related transcription factors have long been implicated in
tumorigenesis; therefore, the putative role of huCOP1 in the path-
ogenesis of human cancers emerged early [11,20]. Much evidence
demonstrating that COP1 plays a major role in tumorigenesis has
since accumulated [25]. However, it is still unclear whether COP1
is a tumor suppressor or an oncogene. Marine speculated in this
recent review that COP1 may have a ‘‘dual face,’’ functioning either
as an oncogene or as a tumor suppressor, depending on the cellular
context.
Our results and the data available in the literature indicate that
decreased huCOP1 levels sensitize the cells to UVB damage or oxi-
dative stress and modify the UVB-induced stress response of
keratinocytes. The loss of some members in the identiﬁed network
increases the sensitivity of the cells to UVB. Maeda et al. [31], for
example, demonstrated that GADD45A/ keratinocytes are more
sensitive to UVB than GADD45A+/+ cells due to reduced DNA
Fig. 5. Predicted upstream regulators of the identiﬁed network. (a) White ovals: upstream regulators; gray rectangles: UVB-upregulated genes of identiﬁed network; white
rectangles: UVB-downregulated genes of the identiﬁed network. All of the upstream regulators were in an activated state, but the relationships among them were not
investigated; (b) relative transcript levels of IL1B, IL6 and NFKB are compared for UVB-irradiated siCOP1 (white bars) and control (black bars) cells. Expression levels were
normalized to the 18S ribosomal RNA gene. Values reﬂect the fold change between the untreated and irradiated control and siCOP1 cells in three independent irradiation
experiments. The applied statistical analysis (Student’s two-tailed heteroscedastic t test) revealed a signiﬁcant (p < 0.05) difference in the expression of the IL6 gene after UVB
irradiation of control and siCOP1 cells and demonstrated a non-signiﬁcant but tendencious difference in the case of IL1B and NFKB gene expression.
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repair and lack of G2/M arrest. It is also well known that the symp-
toms of systemic lupus erythematosus are exacerbated by sun
exposure. Pﬂegerl et al. [32] reported that challenging JUNBDep
mice with UVB irradiation enhanced the severity of their lupus-like
lesions. It has also been published that DAXX-depleted ﬁbroblasts
are resistant to UVB- and oxidative-stress-induced cell death [33].
Presumably, the absence of certain members of the huCOP1-med-
iated transcriptional cascade leads to an abnormal UVB response.
Several members of the identiﬁed huCOP1-mediated
UVB-responsive network have already been correlated with non-
melanoma skin cancers, such as basal cell carcinoma (BCC) and
squamous cell carcinoma (SCC). Immunohistochemical studies
recently performed by our workgroup [34] indicated that huCOP1
expression is altered in both non-melanoma skin cancers.
Moreover, well established data are available on the differential
expression of several members of the identiﬁed huCOP1-mediated
UVB-responsive network both in BCC and SCC [34–38].
We demonstrated that huCOP1 contributes to the transcrip-
tional regulation of the keratinocyte UVB response by the down-
regulation of an UVB inducible network operating through three
newly identiﬁed central organizers. This network is under the con-
trol of upstream regulators also showing UVB response. We
hypothesize that huCOP1 operates as a negative factor of the iden-
tiﬁed transcriptional network by modifying the function of the
upstream regulators. Mechanism underlying the UVB-induced cel-
lular events may include a re-distribution of huCOP1 to different
molecular complexes. Such a mechanism has recently been dem-
onstrated for arabidopsis [8]. The expression of huCOP1 is altered
in non-melanoma skin cancers [34] and several members of the
identiﬁed regulatory network have been implicated in the patho-
genesis of these skin diseases [35–38]. Thus, huCOP1 emerges as
a potential target molecule for BCC and/or SCC. Since COP1 possibly
acts both as an oncogene and as a tumor suppressor, further stud-
ies should clarify the role of huCOP1 for human keratinocytes in
photo-damaged skin and these skin diseases.
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Abstract
In the present study we aim to verify the influence of a non-thermal atmospheric pressure 
plasma on the wound healing process. In this process the major contributors are the 
keratinocytes, which migrate to fill in the gap created by the wound. Therefore, we performed 
the direct treatment of HPV-immortalized human keratinocytes, protected by a layer of 
phosphate buffered saline (PBS) solution, with the glow discharge generated in flowing helium 
by a plasma needle. To mimick a wound, a 4 mm scratch was performed on the cell culture 
(scratch assay). We conducted two types of experiments: (i) cell proliferation and (ii) wound-
healing model experiments. The plasma needle configuration, the plasma treatment conditions 
and the thickness of the protecting PBS layer were set based on viability experiments. The 
proliferation studies showed that short, 5–10 s, and low power treatments, such as 18 W 
and 20 W input power, could positively influence the cell proliferation when keratinocytes 
were protected by PBS. On the other hand, the plasma treatment of cell medium covered 
keratinocytes resulted in the decrease of proliferation. The wound-healing model (scratch 
assay) studies showed, that there was a maximum in the wound reduction as a function of the 
input power and treatment time, namely, at 18 W and 5 s. Furthermore, the wound reduction 
strongly depended on the treated cell—PBS interaction time. To mimic an infected wound, the 
scratch assay was covered with a ×1 109 cfu ml−1 Propionibacterium acnes suspension. The 
plasma treatment of this infected assay resulted in closing of the scratch, while in the non-
treated assay the wound did not close at all.
Keywords: non-thermal atmospheric plasma, biomedical application, cell proliferation
(Some figures may appear in colour only in the online journal)
1. Introduction
During the last decade the attention of plasma community has 
turned towards the therapeutical application of atmospheric 
pressure non-thermal plasmas [1, 2]. One important medical 
application where low-temperature plasmas can have a huge 
potential is the plasma stimulation of living cells and tis-
sues [3–5]. Accordingly, the treatment of chronic wounds by 
plasmas may have selective antimicrobial or antiseptic effect 
without damaging the surrounding tissue, while stimulating 
the tissue regeneration. It has been shown that cold atmo-
spheric plasma (CAP) entails no risk on humans in terms of 
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temperature increase, UV radiation or by free radical forma-
tion by the plasma, while can considerably decrease the bacte-
rial load of the skin [6–8].
Several studies have been conducted aiming to model 
the wound healing process, e.g. the penetration of plasma or 
plasma generated species into the wound mimicking model 
surfaces, such as an agarose gel [9], as well as the transport 
of species and their interaction with the living cells [10, 11]. 
Although the mechanisms of plasma interaction with living 
tissues and cells are very complex, few attempts have been 
made to clarify the physical and biological mechanisms. It has 
been investigated the response of the biological system to the 
different charged species [12], neutral species (such as ROS 
and RNS) and UV radiation [13–15].
In vivo animal experiments have shown that plasma treat-
ment affects the genes that are involved in wound healing, 
tissue injury and repair [16], and promotes tissue healing 
[17, 18]. It has been found that plasma treatment may promote 
the late phase of inflammation, accelerate re-epithelization 
and increase wound contraction [18, 19]. Clinical tests suggest 
that wound healing may be accelerated by plasma treatment, 
particularly for chronic venous ulcers [20].
Investigations conducted at cellular level, such as using 
scratched cell cultures to mimic wounds, can give an insight 
into the elementary processes taking place during the plasma 
treatment. Cell culture studies using human dermal fibroblasts 
showed improved cell migration by plasma jet treatment, 
while the cell proliferation was not altered [16]. In the wound 
healing process the major contributors are the keratinocytes: 
they migrate to fill in the gap created by the wound.
Following the evolution after atmospheric plasma jet treat-
ment of a scratch assay of HaCaT human keratinocytes coc-
ultivated with Staphylococcus epidermidis it has been shown 
that the scratch can close, which indicates the increased cell 
death of S. epidermidis compared to HaCaT keratinocytes 
[21]. The biological changes induced in human keratinocytes 
by direct and indirect treatment with different plasma sources 
have been evaluated and discussed in details in Refs. [22–24]. 
In vivo and in vitro (scratch) assay studies indicated that 
keratinocyte proliferation, migration and apoptotic mecha-
nisms were not affected by the treatment with the cold atmos-
pheric plasma generated with the MicroPlaSter β plasma 
torch system [25]. It has been concluded, that a 2 min treat-
ment with this plasma induces gene expression of key regula-
tors important for inflammation and wound healing without 
causing proliferation, migration or cell death in keratinocytes 
[25]. With our studies we aim to verify the effect of the plasma 
needle—which insures the sample to be in direct contact with 
the active discharge plasma, in contrast with the atmospheric 
plasma jets where only afterglow species reach the sample—
on the proliferation and migration of HPV-immortalized 
human keratinocytes.
The plasma needle is a plasma source with a non-thermal 
atmospheric glow discharge ignited at the tip of a needle. 
From its initial application [26] the plasma needle went 
through a series of transformations, which made it more and 
more suitable for biomedical applications [27–30]. Several 
studies have been conducted, which aimed to investigate the 
effect of the plasma needle on biological samples, such as, 
reattachement and apoptosis of 3T3 mouse fibroblast after 
plasma treatment [31], the proliferation and differentiation 
of mesenchymal stem cells [30], as well as its bactericidal 
effect [29, 33].
The needle configuration chosen for our investigations 
and the experimental set-up used to treat the biological sam-
ples are presented in section 2. The studied cell cultures and 
the analysing methods are described in section 3. Section 4 
discusses the choice of the treatment conditions through the 
viability of cells. The effects of the plasma needle treatment 
on the cell culture are presented in section 5.
2. Experimental setup
2.1. Plasma needle: overview for the choice of the needle 
configuration
The basic plasma needle configuration used in our studies is 
similar to the last generation of plasma needles applied [30, 
34]. In the present case the needle consists of a 0.3 mm diam-
eter central electrode made of wolfram. The needle is covered 
by a slightly larger ceramic tube—except for a 2 mm segment 
at the tip—and placed in a glass tube of 4 mm inner and 6 mm 
outer diameter. The needle body is made of Teflon. Helium 
is flowing between the ceramic and the glass tube, the flow 
rates used are in the 1–1.45 slm (standard liters per minute) 
range. The central electrode is powered by a 13.56 MHz 
power generator (KJLC R601) through a matching net-
work (EJAT3). Plasma is ignited between the needle and 
a grounded electrode. Figure  1 shows different configura-
tions—concerning the position of the tip of the needle rela-
tive to the end of the glass tube and the nature and position 
of the grounded electrode—, which we have been tested 
in order to choose the most suitable configuration for the 
present application. In case of configurations (a), (b) and (e) 
the grounded electrode is served by the support of the plates, 
which contain the liquid protected cell culture. The overall 
aim is to sustain stable glow discharge in contact with the 
liquid surface.
In order to insure a safe distance between the treated 
sample and the needle, which can secure a stable glow opera-
tion without arcing, the needle is pulled inside the glass tube 
with d  =  2–3 mm, see configuration (b) in figure 1. We have 
found that keeping the needle at a ‘safe’ position the arcing 
can be easily avoided, however in this case the plasma tends 
to be confined within the glass tube and mostly the afterglow 
species get in contact with the liquid surface. The biological 
tests have shown that this plasma has no considerable effect 
on the cells. Configuration (c) has been designed for the sake 
of ground stability, as it can assure at any type of treatment 
the same inter-electrode distance. The grounded ring has 
been placed close to the end of the glass tube and different 
positions have been tested. At reasonable gas flow rates we 
could not observe any glow (discharge or afterglow) beyond 
the grounded ring, which indicates that the density of plasma 
species reaching the liquid surface is very low. Nevertheless, 
with this configuration we could prove that plasma radiation 
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has no effect on the cell proliferation. To improve the flow 
of species towards the liquid surface a jet configuration has 
been designed, as shown by configuration (d), and the gas 
flow rate have been increased. This configuration resulted 
much higher gas temperature than the other configurations, 
and it was found not to be very safe for cell treatments as 
additionally a secondary spark like discharge develops to the 
grounded sample. Finally, in order to insure a better access 
into the small diameter well, a glass tube with a conical end 
has been chosen, as shown on configuration (e). In this case 
the same effect has been observed as in case of configura-
tion (d), namely, the density of species reaching the sample 
is very low.
In view of these we have chosen the needle configuration (a), 
where the tip of the needle is in line with the edge of the glass 
tube. In order to make sure that the needle is kept always at the 
safe distance from the sample during treatments, the plasma 
needle has been mounted onto a holder. This distance has been 
set to 1.5 mm, which assures a stable glow discharge operation 
(as illustrated in figure 2) without considerably increasing the 
temperature of PBS during the treatment time. The discharge 
is operated in the 15–30 W input power range and the dissi-
pated plasma power is estimated using the subtraction method 
[35]. According to this method the plasma power is given by 
the difference in nominal power ( −P Pforwarded reflected) with 
and without plasma at the same voltage. The plasma power 
has been found to be less than 500 mW also for the highest 
input power used, similar to the system of Kieft et al [31]. An 
accurate electrical characterization of a similar system can be 
found in the work of Puač et al [32].
2.2. Plasma treatment
We have conducted two types of cell treatment experiments: 
i.e. (i) wound-healing model and (ii) proliferation experi-
ments, which required the use of two different types of cell 
plates. All the experiments have been conducted in a sterile 
biosafety cabinet.
In the first case, for the wound-healing assay treatment we 
used a 24-well plate (Corning, Sigma-Aldrich, USA), which 
has wells of 16 mm diameter and 20 mm height. Here the cells 
attached to the bottom of the well are covered with a PBS 
layer of 1.5 mm thickness, and the needle is approached to 
1.5 mm distance to the PBS surface, as shown in figure 3. The 
flow rate of helium is 1 slm. During treatments the visible 
plasma glow, shown in figure 2, covers a 5 mm diameter cir-
cular area of the sample.
In order to limit the treatment environment to predomi-
nantly helium, the well is covered with a glass lid (see 
figure 3). Optical emission spectrum has been measured using 
an AvaSpec-3648 type spectrometer with 0.2 nm resolution 
and covering a spectral range of 250–800 nm. According to 
the recorded spectra shown in figure 4, the emission is domi-
nated by the He lines, accompanied by the O atomic line, the 
OH and low intensity N2 and 
+N2  bands. The 306 nm emission 
of OH( Σ+A2 — ΠX2 ) transition is found generally when water 
vapour is present, while the first negative system of +N2 ( Σ
+B u
2
— Σ+X g2 ) can be observed in the presence of excess helium 
[36]. The low intensity of the nitrogen bands indicates that the 
discharge is mainly based on helium with small air inflow. We 
Figure 1. Different plasma needle configurations. The glow discharge is ignited between the tip of the powered needle and a grounded 
electrode, that can be the sample holder in the (a), (b) and (e) cases, or the grounded ring positioned close to the glass tube (c) and around 
the glass tube (d), respectively.
Figure 2. A typical image of the plasma needle glow as view 
from side.
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note, that mass spectroscopical analysis of the plasma needle 
glow has been conducted by Malović et al [37] in open envi-
ronment for a given set-up in order to identify the plasma spe-
cies possibly reaching a treated surface. However, these data 
can serve only as a guideline for treatment studies conducted 
under different environmental conditions, as it is the present 
situation.
In the proliferation experiments a 96-well plate has been 
used, which belongs to the xCELLigence microelectronics 
biosensor system for cell-based assays, which provides 
dynamic, real-time, label-free cellular analysis. The wells are 
6 mm in diameter and 10 mm in height. In this case the PBS 
layer is 3.5 mm thick. In order to be able to reach the PBS 
surface the 2 mm segment of the needle that is not covered 
with ceramic is pushed out of the glass tube, as illustrated in 
figure 5. With this configuration the 1.5 mm distance between 
the tip of the needle and the PBS surface could be reached, 
similarly to the wound-healing model experiments. To guar-
antee the helium environment here higher helium flow rate is 
used, i.e. 1.45 slm.
3. Biological samples and analysing methods
3.1. Cell culture
HPV-immortalized human keratinocytes (HPV-KER clone 
II/15) are seeded, according to the procedure described in 
[38, 39], in 500 μl serum-free keratinocyte basal medium 
(KER-SFM, Gibco, Thermo Fisher Scientific Inc, Waltham, 
MA USA) supplemented with 1% L-glutamine and antibiotic/
antimycotic solution containing penicillin, streptomycin and 
amphotericin B (Sigma-Aldrich, USA). Keratinocytes were 
grown at 37 °C in a 5% CO2 atmosphere.
For the proliferation experiments ×5 103 cells per well are 
seeded into the 96-well xCELLigence plates 48 h before per-
forming the plasma treatment.
3.1.1. Scratch assay for wound-healing model. In the case of 
the wound-healing model experiments ×1 105 cells per well 
are seeded into 24-well plates. Before treatment a scratch 
wounding is performed with a cell scraper of 4 mm width, 
Figure 3. Schematic representation of the experimental set-up used in scratched cell assay experiments.
Figure 4. Spectra of the plasma needle ignited in the well covered with a glass lid, which assures predominantly helium environment.
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according to a well-established in vitro wound-healing assay 
[40], as shown in figure 6. For plasma treatment the medium 
covering the keratinocytes are replaced with PBS. The evo-
lution of the scratch in time is observed and recorded using 
a Nikon Eclipse TS100 inverted routine microscope (Nikon 
Incorporation, Melville, USA) fitted with a Nikon Coolpix 
4500 camera (Nikon Incorporation, Melville, USA). The 
width of the scratch is measured using the Gimp2 software. 
The scratch width reduction is calculated by subtraction of 
scratch width at t  =  n h from scratch width at t  =  0 h.
3.1.2. Cocultivation of Propionibacterium acnes and Kerati-
nocytes. P. acnes (ATCC 11828) are cultivated in KER-SFM 
medium with supplements (see section  3.1) during 24 h. In 
order to determine the concentration of P.acnes in suspension 
its optical density at 600 nm is measured by spectrophotometry. 
The bacterial suspension is diluted with PBS to ×1 109  
cfu ml−1 cell density. This suspension is transferred into the 
medium covering the keratinocytes, achieving the multiplicity 
of infection (MOI—the ratio of bacteria per cell) 50 microor-
ganisms. The scratch on the cell culture is performed before 
the transfer of suspension, the size of it and the general cell 
performance are observed during 24 h. One day after plasma 
treatment, keratinocytes are stained with Trypan Blue solution 
0.4% (Sigma Aldrich, St. Louis, MO, USA) to distinguish the 
dead cells from living ones.
3.2. Fluorescent staining
Forty-eight hours after plasma treatment, keratinocytes 
are stained with propidium iodide (PI, BD Pharmingen, 
Heidelberg, Germany) to distinguish dead cells from living 
ones. After washing with calcium- and magnesium-free 
Phosphate-buffered saline (PBS), the cells are incubated with 
PI (final concentration: 1 ug ml−1) for 30 min in the darkness. 
The cells are observed afterwards by confocal laser scanning 
microscopy using an Olympus Fluoview FV1000 confocal 
laser scanning microscope (Olympus Life Science Europa 
GmbH, Hamburg, Germany). The microscope configuration is 
the following: the objective is UPlanSApo 10  ×  (dry, numer-
ical aperture: 0.4), the excitation source is a 543 nm HeNe 
laser, the laser transmissivity is 50%; and the PI (propidium 
iodide) filter settings of the Olympus Fluoview software are 
used for detection.
4. Cell viability: setting the plasma treatment 
conditions
In order to set for the wound-healing model experiments the 
safe treatment conditions, which do not lead to cell death, 
viability experiments are performed. For this purpose 24-well 
plates are used with ×1 105 cells per well. The treatment 
parameters that can influence the cell survival are: (i) input rf 
power, (ii) the thickness of PBS layer protecting the cells from 
desiccation, (iii) treatment time and (iv) the distance between 
the tip of the needle and PBS layer, which are set to 1.5 mm, 
as described in section 2. Cells are treated under different con-
ditions by varying the input power, PBS layer thickness and 
treatment time. The viability of cells at different conditions 
are analysed with staining methods using trypan blue and 
propidium iodide (see section 3.2).
Cells are stained with trypan blue immediately after plasma 
treatment to visualize the effect of the plasma’s structure on 
the cell culture (dead cells take up trypan blue). Figure 7(a) 
shows the image of the cell culture treated in 200 μl PBS 
Figure 5. Schematic representation of the experimental set-up used in proliferation experiments with cells treated in 96-well plates.
Figure 6. Image of the scratched cell culture. For a better contrast 
the assay was painted with Trypan Blue.
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—corresponding to a 1 mm thick PBS layer—for 7 s at 30 W 
input power. Here we see a pattern of dead cells in the area 
covered by the plasma glow. More precisely, most of the cells 
died in the treated region, while the cells in contact with the 
edge of the glow detached and diffused towards the central 
region. On the other hand when 300 μl PBS is used instead of 
200 μl PBS most of the cells remained viable.
A more systematic analysis are carried out with the pro-
pidium iodide staining method. The treated cells are stained 
48 h after plasma treatment. The recorded images of the cells, 
which show the viability of cells—the dead cells stained with 
propidium iodide appear as red—are presented in figure 8. We 
find that the cells covered with 200 μl PBS can survive only 
very short treatments, such as 5 s at an input power of max-
imum 20 W. The increase of the treatment time or the input 
power, both lead to the death of cells. By increasing the PBS to 
250 μl the cells can survive longer treatments at 20 W input power, 
however higher powers are still lethal. When using 300 μl PBS 
the cells can survive treatments as long as 20 s, even at powers 
as high as 35 W.
Viability experiments have also been carried out in 6-well 
plates, with wells of 35 mm diameter. The volume of the PBS 
has been scaled up in order to obtain the same PBS layer thick-
ness as in the case of the 24-well plate experiments. While in 
the 24-well plate the 1 mm PBS layer corresponds to 200 μl, 
in the 6-well plate 962 μl needs to be added to obtain the same 
layer thickness. Treating the cells in the 6-well plate at condi-
tions, which lead to cell death in the 24-well plate—such as 5 s 
treatment at 25 W (shown in figure 8 first row last column)—
most of the cells stayed viable. This result indicates that it is 
not only the PBS layer thickness, but also the liquid surface 
and volume, which influences the density of active species 
reaching the cells. One important parameter can also be the 
heat transport, the heat dissipation increases with the volume 
of the liquid.
In the view of the viability results, in the wound-healing 
experiments, where the 24-well plates are used, the treatment 
Figure 7. (a) The pattern of dead cells caused by plasma treatment 
on cell culture protected with 200 μl PBS, equivalent to 1 mm thick 
layer, when treated for 7 s at 30 W input power. (b) The image of 
cell culture treated in 300 μl PBS for 7 s at 30 W input power. The 
cells are stained with trypan blue, which is taken up by the dead 
cells.
Figure 8. Keratinocytes 48 h after plasma treatment. Image of cells 
recorded by phase-contrast light microscopy (1st, 3rd and 5th rows), 
and confocal laser scanning microscopy image of dead cells stained 
with propidium iodide (2nd, 4th and 6th rows). The treatment 
conditions: PBS layer thickness, input power and treatment time, 
are marked on the images.
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conditions are set as follows: (i) cells are covered with 300 μl 
PBS; (ii) the input power is changed in the 18–30 W range and 
(iii) the treatment time is varied in the 5–30 s range.
5. Results and discussion
5.1. Effect of plasma treatment on cell proliferation
The effect of the plasma treatment on keratinocyte prolifera-
tion are followed with the xCELLigence microelectronics 
biosensor. Each well of the plate belonging to the device con-
tains integral sensor electrode arrays allowing the monitoring 
of cells. The presence of the cells on top of the electrodes 
(i.e. attached to the bottom of the well) affects the local ionic 
environment at the electrode/solution interface, leading to an 
increase in electrode impedance. The more cells are attached 
on the electrodes, the larger is the increase of the electrode 
impedance. The impedance depends also on the quality of 
cell-electrode interaction; for example, increased cell adhe-
sion or spreading will result larger electrode impedance. 
Thus, the electrode impedance displayed as Cell Index values 
reflects not only cell viability and number, but also mor-
phology and adhesion degree, although their deconvolution is 
not straightforward.
The cells, as described in section 2.2, are treated in 96-well 
plates, protected by 100 μl PBS, using input powers in the 
range of 18–30 W and treatment times in the 5–20 s range. 
The 96-well plates are placed back into the xCELLigence bio-
sensor after all the wells have been treated and the PBS have 
been changed back to cell medium. For comparison reasons 
and to verify if the liquid composition influences the effect of 
the treatment, cells are also treated in the cell medium (given 
in section 3.1).
Figure 9 shows the proliferation of keratinocytes treated 
under different conditions in PBS (first column) and cell 
medium (second column). The error bars has been omitted 
from the figures  for better visibility. The maximum error is 
about 12%. We find that treatment of keratinocytes at 18 W 
and 20 W can positively influence the cell proliferation (see 
figures 9(a), (c) and (d)). A more significant increase of pro-
liferation can be observed for the PBS covered cells in the 
case of the 10 s and 15 s long treatments at 20 W (figure 9(c)). 
However, after 60 h the proliferation in the case of treated 
cells falls below the control ones. This behaviour suggests that 
periodical treatments can keep the cell proliferation above the 
normal level. At the same time the increase of the treatment 
time above 15 s, as well as the input power (figures 9(e)–(f)) 
cause the diminishing of the proliferation.
In the case of keratinocytes treated in cell medium we 
can observe a slightly different behaviour, i.e. the cell prolif-
eration enhances at a much higher elapsed time after plasma 
treatment. At 20 W this occurs at 100 h after the treatment, 
except for the longest 20 s treatment. This different behaviour 
shows that due to plasma treatment the liquid chemistry—i.e. 
the created active species, which interact with the cells—in 
the two liquid mediums are different.
We note that the results shown here should not be used for 
quantitative comparison of the different conditions. All the 
treatments have been performed in a single 96-well plate, i.e. 
the cells being treated under different conditions in a row. The 
treatments were done in the following order: (1.) P  =  18 W 
from 5 s to 20 s, (2.) P  =  20 W from 5 s to 20 s, (3.) P  =  25 W 
from 5 s to 20 s, and (4.) P  =  30 W from 5 s to 20 s. As a 
result, the cells interact with the treated liquid for different 
periods of time, which influences the cell’s response to the 
treatment, as also shown in the next section.
5.2. Effect of plasma treatment on wound-healing
For the wound-healing experiments keratinocytes are plated 
into 24-well plates, and the assay is prepared as described in 
section 3.1.1. The cells have been treated as described in sec-
tion 2.2. In a 24-well plate 4 different treatment conditions are 
realized by using 6 samples for each case. Taking into account 
the viability of cells protected by PBS under laboratory con-
ditions, the plates are treated two by two, meaning that the 
cell medium is replaced with PBS in two plates at a time, and 
changed back to medium after both plates have been treated. 
At each input power two plates are treated consecutively as 
follows: in the 1st plate the 5 s, 7 s, 20 s and 25 s treatment 
times are used, while in the 2nd plate the 10 s, 15 s and 30 s 
ones. In the 2nd plate the forth row is occupied by the control 
samples.
Figure 10 shows the evolution of the scratch on the cell 
culture as a function of input power at different elapsed 
times after the plasma treatment. At several treatment condi-
tions—particularly at low treatment times and low powers—
the scratch width reduction is higher than in the case of the 
untreated control, i.e. the closing of the scratch is faster. As 
time elapses, at certain conditions the closing of the scratch 
slows down comparing to the control case, more pronouncedly 
when 25 W and 30 W powers are used. In these cases, at the 
48 h elapsed time the scratch width reduction, independently 
of the treatment time used, falls below the control one (figure 
10(d)). In the case of the lower powers—18 W and 20 W -, the 
conditions of low treatment times become dominant as time 
elapses. This indicates that in order to stimulate the cells, a 
short and low power treatment, which induces stress to the 
cells may be adequate.
Figure 11 presents the closing of the scratch after the low 
power—18 W and 20 W—treatments as a function of treat-
ment time. In both cases the scratch width reduction shows 
similar behaviour, that is a non-monotonous one. With 48 h 
after treatment, the highest scratch width reduction occurs in 
the case of the lowest treatment time 5 s, while the lowest is 
observed in the case of the 15 s treatment. Furthermore, in 
the case of the 25 s treatment a strong increase of the scratch 
closing can be observed. It is suspected, that this non-monoto-
nous behaviour—with a sharp minimum and maximum—can 
be the result of the treatment protocol used. As described in the 
first paragraph of this section, two plates are treated consecu-
tively (‘two-by-two’ protocol), due to which the cells at each 
condition stayed in the treated PBS for different periods of 
time, as presented in table 1. According to this, the minimum 
scratch width reduction can be observed at the conditions, 
where the cells are kept in the treated medium for the shortest 
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period of time. In order to verify this effect and to find out if 
the behaviour depicted in figure 11 should be monotonous, a 
new protocol is chosen, where the plates are treated one by 
one (‘plate-by-plate’ protocol) and in each plate the PBS is 
replaced with the cell medium 10 min after the last treatment 
in the plate. Although in this way we can not equalize the inter-
action times of treated cells and PBS for all conditions, but by 
keeping most of the parameters the same the large differences 
can be diminished as presented in table 2. More precisely, in 
the case of the 10 s and 15 s treatments, where previously the 
minimum in the scratch width reduction has been observed, 
the treated cell—PBS interaction time has been increased to 
the level of the 5 s treatment condition, where previously the 
highest scratch width reduction has been obtained.
Figure 12 shows the evolution of the scratch after the new 
protocol treatments at 18 W input power. According to the 
results, the previously observed sharp minimum and maximum 
of the scratch width reduction as a function of treatment time 
disappears. In the case of the 10 s and 15 s treatments the 
scratch width reduction increases considerably, comparing to 
the previous results shown in figure 11, and as a result a faster 
closing is obtained than in the case of the control sample. This 
result indicates the importance of the treated cell—PBS inter-
action time. However, in the case of the longest treatment here 
Figure 9. Cell Index, showing the cell proliferation, as given by the xCELLigence microelectronics biosensor for initial ×5 103 cells 
treated in PBS (first column) and cell medium (second column) for conditions of different treatment times in the 5–20 s range at input 
powers of 18 W (a)–(b), 20 W (c)–(d) and 25 W (e)–(f), respectively. t  =  0 marks the time moment when the cells have been recovered after 
the plasma treatment.
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investigated—the 30 s treatment—the increase of the treated 
cell—PBS interaction time has no positive effect on the scratch 
closing. Finally, we can still observe a small peak in the scratch 
width reduction as a function of treatment time at 25 s. These 
results indicate that there is a complex relation between the cell 
activation, treatment time and treated cell—PBS interaction 
Figure 10. The scratch closure with (a) 15 h, (b) 24 h, (c) 38 h and (d) 48 h after the plasma treatment as a function of the input power. 
Different symbols mark the different treatment times.
Figure 11. The scratch closure as a function of the treatment time for different elapsed times after treatment at (a) 18 W and (b) 20 W.
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time. The cell activation is influenced both by the direct inter-
action of cells with the plasma and with the species resulted 
from the plasma induced liquid chemistry. The effect of the 
treated cell—medium interaction time on the cells viability has 
been also observed by Strassenburg et al [23].
When treating the PBS protected cell culture directly with 
the plasma needle, the bottom of the well with the attached 
cells serves as the grounded electrode of the rf discharge. 
According to the calculations of Sakiyama et al [41], at a 
sample positioned at 1 mm from the needle the electric field 
is in the range of ×2.5 105 V m−1 in the needle axis, and 
decreases radially to about ×0.5 105 V m−1 in 2 mm.
When treating scratched assays, the keratinocytes are in 
direct contact with the edge of the plasma spot, that is beyond 
2 mm, where the electric field is below ×0.5 105 V m−1. These 
electric fields, according to biological studies, can cause cell 
poration and cell fusion. The threshold field for electro-pora-
tion has been found to be at about 0.3 kV cm−1 [43, 44]. Fields 
as high as 2 kV cm−1 can lead to high cell permeabilization 
with still high viability of cells [42]. However, the cell electro-
poration, which allows different species to cross the cell mem-
brane is cell specific and depends not only on the field strength 
but also on the field frequency and pulse duration [1, 42]. 
The quantum calculations, which predict the experimentally 
observed ‘window effect’—namely, that small electric fields 
do have an influence but large fields do not have—, suggest 
the increase of dermal fibroblasts proliferation for fields in the 
10–1000 mV m−1 range, depending on the frequency [45].
On the other hand, in the case of the proliferation experi-
ments conducted in the 96-well plates, as described in sec-
tion 5.1, the cells are in contact with the full plasma spot, the 
cell culture being exposed to the whole radial field distribution 
of the plasma. Therefore, the differences in the two types of 
experiments may be attributed to the field effect.
In what concerns the chemical change of the treated PBS, 
we did not observe any change in the PH level.
5.3. Cell selectivity of the plasma treatment
In order to mimic an infected wound the keratinocytes have 
been cocultivated with P.acnes Gram-positive bacterium as 
described in section 3.1.2. The cocultivated assay is plasma 
treated as described in section 2.2.
Figure 13 shows the evolution of the scratch in the case 
of the untreated non-infected and P.acnes cocultivated assays, 
respectively, and the plasma treated P.acnes cocultivated assay. 
After 24 h the assay has been stained with trypan blue in order 
to distinguish the dead cells. We see that while in the case of 
the untreated non-infected and the plasma treated P.acnes coc-
ultivated assays the scratch closes, in the case of the untreated 
P.acnes cocultivated assay the scratch width does not decrease 
at all and the keratinocytes all die. On the other hand, in the 
case of the plasma treated sample the keratinocytes do not 
die. This gives evidence that the plasma needle acts selec-
tively regarding the keratinocytes and the Gram-positive bac-
teria. Similar effect has been observed in case of treatment 
of Staphylococcus epidermidis infected HaCaT cells with an 
argon high-frequency driven atmospheric-pressure plasma jet 
treatment [21].
6. Conclusions
The effect of the plasma needle on the wound healing pro-
cess was investigated using HPV-immortalized human 
Table 1. The estimated time while the cells have been covered 
with the treated PBS after the direct plasma treatment of the PBS 
protected cells.
Treatment  
order
Treatment  
time (s)
Estimated elapsed 
time in treated PBS (s)
1 5 1100
2 7 1000
5 10 480
6 15 330
3 20 820
4 25 600
7 30 90
Note: The seven different length of treatments have been realized in two 
consecutively treated 24-well plates. The PBS is removed after both plates 
are fully treated. The different elapsed times occur from the treatment order 
of the PBS covered cells.
Table 2. The estimated time while the cells have been covered 
with the treated PBS after the direct plasma treatment of the PBS 
protected cells, when the plates are treated one by one and PBS is 
removed with 10 min after the plate has been fully treated.
Treatment 
order
Plate  
ID
Treatment 
time (s)
Estimated elapsed 
time in treated PBS (s)
1 1 5 1100
2 1 7 1000
1 2 10 1100
2 2 15 950
3 1 20 820
4 1 25 600
3 2 30 690
Figure 12. The scratch closure as a function of the treatment time 
for different elapsed times (marked with the same symbols as in 
figure 11) after the plasma treatment at 18 W using the ‘plate-by-
plate’ treatment protocol described in the text.
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keratinocytes. The wound was modeled with a 4 mm scratch 
made on the cell culture. The cells protected by a layer of 
phosphate buffered saline (PBS) solution were directly treated 
with the plasma generated in flowing helium by a plasma 
needle. We conducted two types of experiments: (i) cell pro-
liferation and (ii) wound-healing model experiments. The 
plasma needle configuration, the plasma treatment conditions 
and the thickness of the protecting PBS layer were set based 
on viability experiments. We found that the minimum PBS 
layer necessary to protect the cells during treatment depended 
on the wells’ dimensions, namely, in larger wells thinner layer 
appeared to be enough to protect the cells. This shows the dif-
ficulty of scaling the treatment conditions.
The proliferation studies showed that short, 5–10 s, and low 
power treatments, such as 18 W and 20 W input power, could 
positively influence the cell proliferation when keratinocytes 
were protected by PBS. We also found, that the cells treated 
in cell medium were more affected than those treated in PBS 
(i.e. cell proliferation decreased), which shows that the plasma 
induced liquid chemistry—i.e. the created active species, 
which interact with the cells—in the two liquid mediums were 
different. Therefore, the choice of the interaction medium is 
very important when setting the treatment conditions.
Monitoring the reduction of the scratch width after plasma 
treatment for 48 h, we found that there was a maximum in the 
wound reduction as a function of the input power and treatment 
time, namely, at 18 W and 5 s. Nevertheless, favourable condi-
tions were also found in the case of 18 W and 20 W input powers 
and 5–25 s long treatments. We also found, that the wound reduc-
tion strongly depended on the treated cell—PBS interaction time.
To mimic an infected wound, the scratch assay was cov-
ered with a ×1 109 cfu ml−1 Propionibacterium acnes sus-
pension. The plasma treatment of this infected assay resulted 
in closing of the scratch, while in the non-treated assay the 
wound did not close at all.
The results suggest, that for activation of the healing pro-
cess small stress induced to the keratinocytes is enough, and 
the treatment medium should be carefully chosen.
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